{"parse":{"title":"Burzynski Clinic","pageid":1018018,"revid":859721775,"text":{"*":"<div class=\"mw-parser-output\"><p class=\"mw-empty-elt\">\n\n</p><p>The <b>Burzynski Clinic</b> is a controversial clinic offering unproven <a href=\"/wiki/Cancer_treatment\" class=\"mw-redirect\" title=\"Cancer treatment\">cancer treatment</a>. It was founded in 1976 and is in <a href=\"/wiki/Texas\" title=\"Texas\">Texas</a>, <a href=\"/wiki/United_States\" title=\"United States\">United States</a>. It is best known for the controversial \"antineoplaston therapy\", using compounds it calls antineoplastons, devised by the clinic's founder Stanislaw Burzynski in the 1970s. There is no accepted scientific evidence of benefit from antineoplaston combinations for various diseases.\n</p><p>The clinic has been the focus of criticism primarily due to the way its antineoplaston therapy is promoted, the costs for people with cancer participating in \"trials\" of antineoplastons, problems with the way these trials are run, and legal cases brought as a result of the sale of the therapy without state board approval.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Stanislaw_Burzynski\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Stanislaw Burzynski</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Antineoplaston_therapy\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Antineoplaston therapy</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Clinical_trials\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Clinical trials</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Efficacy\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Efficacy</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Cost\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Cost</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Legal_issues\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Legal issues</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#FDA_warnings\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">FDA warnings</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Texas_Medical_Board\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Texas Medical Board</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Lawsuits\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Lawsuits</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Legal_threats_to_online_critics\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Legal threats to online critics</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Media_and_commentary\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Media and commentary</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#Further_reading\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-14\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Stanislaw_Burzynski\">Stanislaw Burzynski</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=1\" title=\"Edit section: Stanislaw Burzynski\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Burzynski was born on January 23, 1943 in <a href=\"/wiki/Lublin\" title=\"Lublin\">Lublin</a>, <a href=\"/wiki/Poland\" title=\"Poland\">Poland</a>. He graduated from the <a href=\"/wiki/Medical_University_of_Lublin\" title=\"Medical University of Lublin\">Medical Academy in Lublin</a>.<sup id=\"cite_ref-Smith1992_1-0\" class=\"reference\"><a href=\"#cite_note-Smith1992-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-cjc_2-0\" class=\"reference\"><a href=\"#cite_note-cjc-2\">&#91;2&#93;</a></sup> The following year he earned a Ph.D. in biochemistry.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p>Burzynski moved to the <a href=\"/wiki/United_States\" title=\"United States\">United States</a> in 1970, working at <a href=\"/wiki/Baylor_College_of_Medicine\" title=\"Baylor College of Medicine\">Baylor College</a> until 1977, when he established the Burzynski Research Laboratory where he administered antineoplaston therapy, initially to 21 patients but then more widely as \"experimental\" treatment. This opened him up to \"charges of unethical conduct and to the suspicion he had become a merchant of false hope\", which led to several instances of media controversy.<sup id=\"cite_ref-Smith1992_1-1\" class=\"reference\"><a href=\"#cite_note-Smith1992-1\">&#91;1&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>138</span></sup>\n</p><p>Burzynski founded the Burzynski Research Institute in 1984.<sup id=\"cite_ref-BRI_4-0\" class=\"reference\"><a href=\"#cite_note-BRI-4\">&#91;4&#93;</a></sup>  His scientific papers have caused academic controversy, with reviewers disputing the design of the trials and scientific validity of the published results.<sup id=\"cite_ref-vickers_5-0\" class=\"reference\"><a href=\"#cite_note-vickers-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-rocco_6-0\" class=\"reference\"><a href=\"#cite_note-rocco-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-Blaskiewicz_7-0\" class=\"reference\"><a href=\"#cite_note-Blaskiewicz-7\">&#91;7&#93;</a></sup>\n</p><p>In February 2017 following lengthy hearings the Texas Medical Board recommended Burzynski's medical license be revoked, with the revocation suspended, and a fine of $360,000 for billing irregularities and other violations.<sup id=\"cite_ref-HoustonPressFine_8-0\" class=\"reference\"><a href=\"#cite_note-HoustonPressFine-8\">&#91;8&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Antineoplaston_therapy\">Antineoplaston therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=2\" title=\"Edit section: Antineoplaston therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><i>Antineoplaston</i> is a name coined by Burzynski for a group of <a href=\"/wiki/Peptides\" class=\"mw-redirect\" title=\"Peptides\">peptides</a>, peptide derivatives, and mixtures that he uses as an <a href=\"/wiki/Alternative_cancer_treatment\" class=\"mw-redirect\" title=\"Alternative cancer treatment\">alternative cancer treatment</a>.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> The word is derived from <i><a href=\"/wiki/Neoplasm\" title=\"Neoplasm\">neoplasm</a></i>.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>Antineoplaston therapy has been offered in the U.S. since 1984 but is not approved for general use.  The compounds are not licensed as drugs but are instead sold and administered as part of clinical trials at the Burzynski Clinic and the Burzynski Research Institute.<sup id=\"cite_ref-NCIfaq_11-0\" class=\"reference\"><a href=\"#cite_note-NCIfaq-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-pmid16484713_13-0\" class=\"reference\"><a href=\"#cite_note-pmid16484713-13\">&#91;13&#93;</a></sup>\n</p><p>Burzynski stated that he began investigating the use of antineoplastons after detecting what he considered significant differences in the presence of peptides between the blood of cancer patients and a control group.<sup id=\"cite_ref-Burzy1986_14-0\" class=\"reference\"><a href=\"#cite_note-Burzy1986-14\">&#91;14&#93;</a></sup> He first identified antineoplastons from human blood. Since similar peptides had been isolated from urine, early batches of Burzynski's treatment were isolated from urine.<sup id=\"cite_ref-Burzy1986_14-1\" class=\"reference\"><a href=\"#cite_note-Burzy1986-14\">&#91;14&#93;</a></sup> Burzynski has since produced the compounds synthetically.<sup id=\"cite_ref-Marshall1994_15-0\" class=\"reference\"><a href=\"#cite_note-Marshall1994-15\">&#91;15&#93;</a></sup>\n</p><p>The first active peptide fraction identified was called antineoplaston A-10 (3-phenylacetylamino-2,6-piperidinedione).  From A-10, antineoplaston AS2-1 was derived \u2013 a 4:1 mixture of <a href=\"/wiki/Phenylacetic_acid\" title=\"Phenylacetic acid\">phenylacetic acid</a> and <a href=\"/wiki/Phenylacetylglutamine\" title=\"Phenylacetylglutamine\">phenylacetylglutamine</a>.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> The Burzynski Clinic website states that the active ingredient of antineoplaston A10-I is <a href=\"/wiki/Phenylacetylglutamine\" title=\"Phenylacetylglutamine\">phenylacetylglutamine</a>.<sup id=\"cite_ref-pmid16484713_13-1\" class=\"reference\"><a href=\"#cite_note-pmid16484713-13\">&#91;13&#93;</a></sup>\n</p><p>Since 2011, the clinic has marketed itself as offering \"personalized gene-targeted cancer therapy\", which has stirred further controversy, as the treatment bears no relationship to gene-targeted therapy and only superficially incorporates elements of <a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">personalized medicine</a>.<sup id=\"cite_ref-SBM1_17-0\" class=\"reference\"><a href=\"#cite_note-SBM1-17\">&#91;17&#93;</a></sup>  The clinic's version of personalized medicine bears little resemblance to <a href=\"/wiki/Targeted_cancer_therapy\" class=\"mw-redirect\" title=\"Targeted cancer therapy\">targeted cancer therapy</a>, as the clinic includes <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a> drugs and antineoplastons are part of this treatment.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Clinical_trials\">Clinical trials</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=3\" title=\"Edit section: Clinical trials\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">For definitions of clinical trial phases, see <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trial</a>.</div>\n<p>According to the <a href=\"/wiki/National_Cancer_Institute\" title=\"National Cancer Institute\">National Cancer Institute</a>, as of April 2013, \"no phase III randomized, controlled trials of antineoplastons as a treatment for cancer have been conducted. Publications have taken the form of case reports, phase I clinical trials, toxicity studies, and phase II clinical trials\",<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> and  \"for the most part, these publications have been authored by the developer of the therapy, Dr. Burzynski, in conjunction with his associates at the Burzynski Clinic. Although these studies often report remissions, other investigators have not been successful in duplicating these results.\"<sup id=\"cite_ref-NCIsummary_21-0\" class=\"reference\"><a href=\"#cite_note-NCIsummary-21\">&#91;21&#93;</a></sup>\n</p><p>From 1991 to 1995, the NCI initiated multiple phase II trials of antineoplastons. In 1995, after over $1 million had been spent on these trials, they were stopped before the effectiveness of antineoplastons could be determined.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p><p>Since the mid-1990s, Burzynski registered some sixty clinical trials of antineoplastons and, in December 2010, a Phase III trial which did not open for patient recruitment. Burzynski has not published full results for any of these.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> According to his lawyer, Richard Jaffe:\n</p>\n<style data-mw-deduplicate=\"TemplateStyles:r856303468\">.mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}</style><blockquote class=\"templatequote\"><p>[...] Burzynski personally put together seventy-two protocols to treat every type of cancer the clinic had treated and everything Burzynski wanted to treat in the future. [...] We heard that the FDA had to put together a fifty-person task force to review all of the protocols Burzynski submitted.<sup id=\"cite_ref-Jaffe_25-0\" class=\"reference\"><a href=\"#cite_note-Jaffe-25\">&#91;25&#93;</a></sup>\n</p></blockquote>\n<p>All trials were paused (no new patients allowed) following a 2013 FDA inspections which found (for the third consecutive time) significant issues with his Institutional Review Board, and, according to papers published in November 2013, substantial issues with the conduct of both the clinic and Burzynski as principal investigator.<sup id=\"cite_ref-USA_Today_26-0\" class=\"reference\"><a href=\"#cite_note-USA_Today-26\">&#91;26&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Efficacy\">Efficacy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=4\" title=\"Edit section: Efficacy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Although Burzynski and his associates claim success in the use of antineoplaston combinations for the treatment of various diseases, and some of the clinic's patients say they have been helped,<sup id=\"cite_ref-ACS1_27-0\" class=\"reference\"><a href=\"#cite_note-ACS1-27\">&#91;27&#93;</a></sup> there is no evidence of the clinical <a href=\"/wiki/Efficacy\" title=\"Efficacy\">efficacy</a> of these methods. The consensus among the professional community, as represented by the <a href=\"/wiki/American_Cancer_Society\" title=\"American Cancer Society\">American Cancer Society</a><sup id=\"cite_ref-ACS1_27-1\" class=\"reference\"><a href=\"#cite_note-ACS1-27\">&#91;27&#93;</a></sup> and <a href=\"/wiki/Cancer_Research_UK\" title=\"Cancer Research UK\">Cancer Research UK</a><sup id=\"cite_ref-cancer-uk_28-0\" class=\"reference\"><a href=\"#cite_note-cancer-uk-28\">&#91;28&#93;</a></sup> among others, is that antineoplaston therapy is unproven and the overall probability of the treatment turning out to be as claimed is low due to lack of credible mechanisms and the poor state of research after more than 35 years of investigation. While the antineoplaston therapy is marketed as a non-toxic alternative to chemotherapy, it is a form of chemotherapy with significant known side effects including severe <a href=\"/wiki/Neurotoxicity\" title=\"Neurotoxicity\">neurotoxicity</a>.<sup id=\"cite_ref-SBM1_17-1\" class=\"reference\"><a href=\"#cite_note-SBM1-17\">&#91;17&#93;</a></sup><sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup>\n</p><p>Independent scientists have been <a href=\"/wiki/Reproducibility\" title=\"Reproducibility\">unable to reproduce</a> the positive results reported in Burzynski's studies: NCI observed that researchers other than Burzynski and his associates have not been successful in duplicating his results,<sup id=\"cite_ref-NCIsummary_21-1\" class=\"reference\"><a href=\"#cite_note-NCIsummary-21\">&#91;21&#93;</a></sup> and <a href=\"/wiki/Cancer_Research_UK\" title=\"Cancer Research UK\">Cancer Research UK</a> states that \"available scientific evidence does not support claims that antineoplaston therapy is effective in treating or preventing cancer.\"<sup id=\"cite_ref-cancer-uk_28-1\" class=\"reference\"><a href=\"#cite_note-cancer-uk-28\">&#91;28&#93;</a></sup>\n</p><p>There is no convincing evidence from <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized controlled trials</a> in the <a href=\"/wiki/Scientific_literature\" title=\"Scientific literature\">scientific literature</a> that antineoplastons are useful treatments of cancer, and the U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) has not approved these products for the treatment of any disease.<sup id=\"cite_ref-NCIfaq_11-1\" class=\"reference\"><a href=\"#cite_note-NCIfaq-11\">&#91;11&#93;</a></sup> The <a href=\"/wiki/American_Cancer_Society\" title=\"American Cancer Society\">American Cancer Society</a> has stated since 1983 that there is no evidence that antineoplastons have any beneficial effects in cancer and recommended that people do not buy these products since there could be serious health consequences.<sup id=\"cite_ref-ACS1_27-2\" class=\"reference\"><a href=\"#cite_note-ACS1-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-Antineoplastic1983_30-0\" class=\"reference\"><a href=\"#cite_note-Antineoplastic1983-30\">&#91;30&#93;</a></sup> A 2004 medical review described antineoplaston treatment as a \"disproven therapy\".<sup id=\"cite_ref-vickers_5-1\" class=\"reference\"><a href=\"#cite_note-vickers-5\">&#91;5&#93;</a></sup>\n</p><p>In 1998, three <a href=\"/wiki/Oncology\" title=\"Oncology\">oncologists</a> were enlisted by the weekly Washington newsletter <i>The Cancer Letter</i> to conduct independent reviews of Burzynski's clinical trial research on antineoplastons. They concluded that the studies were poorly designed, not interpretable, and \"so flawed that it cannot be determined whether it really works\". One of them characterized the research as \"scientific nonsense\".<sup id=\"cite_ref-langford1998_31-0\" class=\"reference\"><a href=\"#cite_note-langford1998-31\">&#91;31&#93;</a></sup> In addition to questioning Burzynski's research methods, the oncologists found significant and possibly life-threatening toxicity in some patients treated with antineoplastons.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p><p>The <a href=\"/wiki/Memorial_Sloan-Kettering_Cancer_Center\" class=\"mw-redirect\" title=\"Memorial Sloan-Kettering Cancer Center\">Memorial Sloan-Kettering Cancer Center</a> has stated: \"Bottom Line: There is no clear evidence to support the anticancer effects of antineoplastons in humans.\"<sup id=\"cite_ref-MSKCC_33-0\" class=\"reference\"><a href=\"#cite_note-MSKCC-33\">&#91;33&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Cost\">Cost</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=5\" title=\"Edit section: Cost\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>According to the American Cancer Society, \"Treatment can cost from $7,000 to $9,500 per month or more, depending on the type of treatment, number of consultations, and the need for surgery to implant a catheter for drug delivery. Available information suggests that health insurance plans often do not reimburse costs linked to this treatment.\"<sup id=\"cite_ref-ACS1_27-3\" class=\"reference\"><a href=\"#cite_note-ACS1-27\">&#91;27&#93;</a></sup>  As of March 2015, the Burzynski Clinic required patients to provide a deposit before treatment starts and their website informed patients that \"Since we are classified as \"out of network\" we are unable to accept Medicare, Medicaid and any HMO insurance\".<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Legal_issues\">Legal issues</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=6\" title=\"Edit section: Legal issues\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"FDA_warnings\">FDA warnings</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=7\" title=\"Edit section: FDA warnings\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Burzynski's use and advertising of antineoplastons as an unapproved cancer therapy were deemed to be unlawful by the U.S. FDA and the <a href=\"/wiki/Texas_Attorney_General\" title=\"Texas Attorney General\">Texas Attorney General</a>,<sup id=\"cite_ref-opinion_35-0\" class=\"reference\"><a href=\"#cite_note-opinion-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-openjurist1987_36-0\" class=\"reference\"><a href=\"#cite_note-openjurist1987-36\">&#91;36&#93;</a></sup> and limits on the sale and advertising of the treatment were imposed as a result.\n</p><p>In 2009, the <a href=\"/wiki/FDA_Warning_Letter\" class=\"mw-redirect\" title=\"FDA Warning Letter\">FDA issued a warning letter</a> to the Burzynski Research Institute, stating that an investigation had determined the Burzynski <a href=\"/wiki/Institutional_Review_Board\" class=\"mw-redirect\" title=\"Institutional Review Board\">Institutional Review Board</a> (IRB) \"did not adhere to the applicable statutory requirements and FDA regulations governing the <a href=\"/wiki/Human_subject_research\" title=\"Human subject research\">protection of human subjects</a>.\" It identified a number of specific findings, among them that the IRB had approved research without ensuring risk to patients was minimized, had failed to prepare required written procedures or retain required documentation, and had failed to conduct required continuing reviews for studies, among others.  The Institute was given fifteen days to identify the steps it would take to prevent future violations.<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup>\n</p><p>\nAnother warning issued in October 2012 notes that the Burzynski Clinic is advertising investigational drugs as being \"safe and effective\", noting: </p><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r856303468\"/><blockquote class=\"templatequote\"><p>Promotion of an investigational new drug is prohibited under FDA regulations at 21 CFR 312.7(a), which states, \"A sponsor or investigator, or any person acting on behalf of a 1 sponsor or investigator, shall not represent in a promotional context that an investigational new drug is safe or effective for the purposes for which it is under investigation or otherwise promote the drug. This provision is not intended to restrict the full exchange of scientific information concerning the drug, including dissemination of scientific findings in scientific or lay media. Rather, its intent is to restrict promotional claims of safety or effectiveness of the drug for a use for which it is under investigation and to preclude commercialization of the drug before it is approved for commercial distribution.\"<br /><br />The websites, including the posted press releases and embedded videos, contain claims such as the following that promote Antineoplastons as safe and/or effective for the purposes for which they are being investigated or otherwise promote the drugs. [...] Since Antineoplastons are investigational new drugs, the products' indication(s), warnings, precautions, adverse reactions, and dosage and administration have not been established and are unknown at this time. Promoting Antineoplastons as safe and effective for the purposes for which they are under investigation, by making representations such as those noted above, is in violation of 21 CFR 312.7(a).</p><div class=\"templatequotecite\">\u2014&#8201;<cite>FDA enforcement letter, <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM326631.pdf\">Original</a></cite></div>\n</blockquote>\n<p>The letter requires cessation of noncompliant promotional activities, including use of testimonials and promotional interviews with Burzynski himself.<sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup>\n</p><p>In June 2012, antineoplaston trials were paused following the death of a child patient. In January and February 2013, the FDA inspected Burzynski and his IRB in Houston. In December 2013, the FDA issued its findings in warning letters to Burzynski, expressing \"concerns about subject safety and data integrity, as well as concerns about the adequacy of safeguards in place at your site to protect patients....\"<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup>\n</p><p>In November 2013 the FDA released the observational notes from an inspection of Burzynski as a principal investigator that took place between January and March 2013. Among the findings were \u201c[failure] to comply with protocol requirements related to the primary outcome, therapeutic response [...], for 67% of study subjects reviewed during the inspection,\u201d admitting patients who failed to meet inclusion criteria, failing to stop treatment when patients had severe toxic reactions to antineoplastons, and failure to report all adverse events. Further, the FDA told Burzynski, \"You failed to protect the rights, safety, and welfare of subjects under your care. Forty-eight (48) subjects experienced 102 investigational overdoses between January 1, 2005 and February 22, 2013 [...] There is no documentation to show that you have implemented corrective actions during this time period to ensure the safety and welfare of subjects.\u201d The FDA also observed that Burzynski had denied patients informed consent by not informing them of extra costs that they might incur during treatment and that he could not account for his stock of the investigational drug. Lastly, the FDA observed: \"Your [...] tumor measurements initially recorded on worksheets at baseline and on-study treatment [...] studies for all study subjects were destroyed and are not available for FDA inspectional review\", meaning that there was no way for the FDA to verify either initial tumor sizes or effects that the antineoplastons may have had.<sup id=\"cite_ref-USA_Today_26-1\" class=\"reference\"><a href=\"#cite_note-USA_Today-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup><sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup>\n</p><p>In Burzynski's written response to the 2013 FDA investigation he states that the investigators '\"complied with all criteria for evaluation of response and made accurate assessments for tumor response.\"'<sup id=\"cite_ref-USA_Today_26-2\" class=\"reference\"><a href=\"#cite_note-USA_Today-26\">&#91;26&#93;</a></sup>\n</p><p>In December 2013, the FDA issued two warning letters, one to the Burzynski Institutional Review Board and one to Burzynski, the subjects of the investigations in February. The FDA found that Burzynski and the IRB had largely failed to address the concerns identified in the initial observation reports. The letter to Burzynski noted serious problems with patient medical files with respect to a pediatric patient who died while treated by Burzynski<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> and whose death apparently initiated the investigation.<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup>\n</p><p>On March 23, 2014, <i>USA Today</i> reported that the FDA had decided to permit \"a handful\" of cancer patients to receive Burzynski's treatment provided that the patients did not receive the treatment directly from him.<sup id=\"cite_ref-USA_Today_FDA_agrees_45-0\" class=\"reference\"><a href=\"#cite_note-USA_Today_FDA_agrees-45\">&#91;45&#93;</a></sup>\n</p><p><a href=\"/wiki/David_Gorski\" title=\"David Gorski\">David Gorski</a> wrote in 2014 that over four decades the FDA and state medical boards have been unable to shut down Burzynkski's business selling unproven treatments \u2013 \"these organizations are supposed to protect the public from practitioners like Burzynski, but all too often they fail at their charges, in this case spectacularly.\"<sup id=\"cite_ref-4decs_46-0\" class=\"reference\"><a href=\"#cite_note-4decs-46\">&#91;46&#93;</a></sup>\n</p><p>The Burzynski Clinic has also made use of compassionate use exemptions. According to an investigative report by STAT News published in August 2016, the clinic has benefited by political lobbying of Burzynski's supporters, including the families of patients with terminal diagnoses. According to FDA documents obtained by STAT, \"From 2011 to 2016, 37 members of Congress wrote to the FDA about Burzynski. [&#8230;] Most of the lawmakers asked the agency to grant constituents 'compassionate use exemptions' so that they could try his unapproved drugs, or to allow his clinical trials to proceed.\"<sup id=\"cite_ref-statnews-2016_47-0\" class=\"reference\"><a href=\"#cite_note-statnews-2016-47\">&#91;47&#93;</a></sup> According to Burzynski, \"interventions by lawmakers were helpful.\"<sup id=\"cite_ref-statnews-2016_47-1\" class=\"reference\"><a href=\"#cite_note-statnews-2016-47\">&#91;47&#93;</a></sup>\n</p><p>However, appeals to the FDA compassionate use exemptions are not always successful. In one case, \"Burzynski said he used a Texas state law to circumvent the agency and start treatment.\"<sup id=\"cite_ref-statnews-2016_47-2\" class=\"reference\"><a href=\"#cite_note-statnews-2016-47\">&#91;47&#93;</a></sup> Critics state that \"the congressional advocacy risks giving the terminally ill and their families a false sense of hope, while also conferring a measure of legitimacy on him that many believe he does not deserve.\".<sup id=\"cite_ref-statnews-2016_47-3\" class=\"reference\"><a href=\"#cite_note-statnews-2016-47\">&#91;47&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Texas_Medical_Board\">Texas Medical Board</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=8\" title=\"Edit section: Texas Medical Board\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In December 2010, the use of <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapeutic agents</a> by the clinic has been characterized as \"random\" and their use of unapproved combinations \"with no known benefits but clear harms\" by the <a href=\"/wiki/Texas_Medical_Board\" title=\"Texas Medical Board\">Texas Medical Board</a>, which regulates and licenses physicians in the state of Texas, led to a case against Burzynski by that board. Burzynski was acquitted because he had not personally written the prescriptions.<sup id=\"cite_ref-USA_Today_26-3\" class=\"reference\"><a href=\"#cite_note-USA_Today-26\">&#91;26&#93;</a></sup>\n</p><p>In July 2014, the board filed a 202-page complaint against Burzynski to the Texas State Office of Administrative Hearings.<sup id=\"cite_ref-tmb-2014_48-0\" class=\"reference\"><a href=\"#cite_note-tmb-2014-48\">&#91;48&#93;</a></sup><sup id=\"cite_ref-brooks-2014_49-0\" class=\"reference\"><a href=\"#cite_note-brooks-2014-49\">&#91;49&#93;</a></sup> The complaint addressed allegations by the Board including misleading patients into paying exorbitant charges,<sup id=\"cite_ref-tmb-2014_48-1\" class=\"reference\"><a href=\"#cite_note-tmb-2014-48\">&#91;48&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>2</span></sup> misrepresenting unlicensed persons to patients as licensed medical doctors,<sup id=\"cite_ref-tmb-2014_48-2\" class=\"reference\"><a href=\"#cite_note-tmb-2014-48\">&#91;48&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>2,4\u20136,28\u201331,50\u201353</span></sup> and misleading patients into accepting care from providers without significant education or training related to cancer treatment.<sup id=\"cite_ref-tmb-2014_48-3\" class=\"reference\"><a href=\"#cite_note-tmb-2014-48\">&#91;48&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>2</span></sup> Citing examples of problems with 29 patients, which were listed in the document, the board said that \"unapproved combinations of highly toxic chemotherapy\" were prescribed \"in ways that caused harm to several patients.\"<sup id=\"cite_ref-szabo-July2014_50-0\" class=\"reference\"><a href=\"#cite_note-szabo-July2014-50\">&#91;50&#93;</a></sup> In July 2015, Burzynski's counsel, Richard Jaffe, withdrew from the case citing a potential conflict of interest,<sup id=\"cite_ref-51\" class=\"reference\"><a href=\"#cite_note-51\">&#91;51&#93;</a></sup> a result of Jaffe pursuing actions against Burzynski in bankruptcy court.<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup> With the addition of replacement counsel, the hearing was set to begin in November 2015.<sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup>\n</p><p>In November 2015, the Texas Medical Board took Burzynski to court in Houston, Texas. Burzynski was accused of <a href=\"/wiki/Bait-and-switch\" title=\"Bait-and-switch\">bait-and-switch</a> tactics, improperly charging patients, not informing patients that he owns the pharmacy they were required to use to fill their medications, and of <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label prescribing</a> of drugs. Burzynski's former attorney Richard Jaffe has filed suit in Federal Court claiming unpaid legal fees of over $250,000. Burzynski through his current attorney denied all charges.<sup id=\"cite_ref-54\" class=\"reference\"><a href=\"#cite_note-54\">&#91;54&#93;</a></sup>\n</p><p>On March 3, 2017, the Texas Medical Board sanctioned Burzynski, placing him on probation and fining him $40,000.<sup id=\"cite_ref-Chang2017a_55-0\" class=\"reference\"><a href=\"#cite_note-Chang2017a-55\">&#91;55&#93;</a></sup> After being sanctioned for over 130 violations, he was allowed to keep his medical license and to continue to practice.<sup id=\"cite_ref-56\" class=\"reference\"><a href=\"#cite_note-56\">&#91;56&#93;</a></sup>Staff recommendations had been more punitive.<sup id=\"cite_ref-Chang2017a_55-1\" class=\"reference\"><a href=\"#cite_note-Chang2017a-55\">&#91;55&#93;</a></sup><sup id=\"cite_ref-TMBproposedJudgement_57-0\" class=\"reference\"><a href=\"#cite_note-TMBproposedJudgement-57\">&#91;57&#93;</a></sup> Probation terms included additional medical training, disclosure of the Board's ruling to patients and medical facilities, and monitoring of his patient records.<sup id=\"cite_ref-Chang2017b_58-0\" class=\"reference\"><a href=\"#cite_note-Chang2017b-58\">&#91;58&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Lawsuits\">Lawsuits</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=9\" title=\"Edit section: Lawsuits\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 1983, a federal court issued an injunction against Burzynski, barring him from shipping antineoplastons in <a href=\"/wiki/Interstate_commerce\" class=\"mw-redirect\" title=\"Interstate commerce\">interstate commerce</a> without FDA approval. Burzynski continued to use antineoplastons and was charged with 75 federal counts of mail fraud and violations of federal drug laws. In 1994, a 20-day trial resulted in the dismissal of the 34 counts of mail fraud. On the other 41 counts, the jury deadlocked, failing to come to a verdict.<sup id=\"cite_ref-MaxwellMayo_59-0\" class=\"reference\"><a href=\"#cite_note-MaxwellMayo-59\">&#91;59&#93;</a></sup> In a separate <a href=\"/wiki/Administrative_law\" title=\"Administrative law\">administrative proceeding</a>, the Texas State Board of Medical Examiners charged Burzynski with violations of Texas state law relating to his use of antineoplastons. An <a href=\"/wiki/Administrative_law_judge\" title=\"Administrative law judge\">administrative law judge</a> ruled that Burzynski violated a section of the Texas Health and Safety Code dealing with prescriptions for unapproved drugs. The <a href=\"/wiki/Texas_Court_of_Appeals\" class=\"mw-redirect\" title=\"Texas Court of Appeals\">Texas Court of Appeals</a> ultimately upheld this determination in a 1996 decision.<sup id=\"cite_ref-MaxwellMayo_59-1\" class=\"reference\"><a href=\"#cite_note-MaxwellMayo-59\">&#91;59&#93;</a></sup>\n</p><p>In December 2010, the Texas State Board of Medical Examiners filed a multi-count complaint in the <a href=\"/wiki/Texas_State_Office_of_Administrative_Hearings\" title=\"Texas State Office of Administrative Hearings\">Texas State Office of Administrative Hearings</a> against Burzynski for failure to meet state medical standards.<sup id=\"cite_ref-TexasMedBoard_60-0\" class=\"reference\"><a href=\"#cite_note-TexasMedBoard-60\">&#91;60&#93;</a></sup> In November 2012, a Texas State Office of Administrative Hearings administrative law judge ruled that Burzynski was not <a href=\"/wiki/Vicarious_liability\" title=\"Vicarious liability\">vicariously liable</a> under Texas administrative law for the actions of staff at the clinic.<sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup> \n</p><p>In January 2012, Lola Quinlan, an elderly, stage IV cancer patient, sued Burzynski for using false and misleading tactics to \"swindle her out of $100,000\". She also sued his companies, The Burzynski Clinic, the Burzynski Research Institute and Southern Family Pharmacy, in Harris County Court. She sued for negligence, negligent misrepresentation, fraud, deceptive trade and conspiracy.<sup id=\"cite_ref-Langford_62-0\" class=\"reference\"><a href=\"#cite_note-Langford-62\">&#91;62&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Legal_threats_to_online_critics\">Legal threats to online critics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=10\" title=\"Edit section: Legal threats to online critics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In November 2011, a music writer and editor for the British newspaper <i><a href=\"/wiki/The_Observer\" title=\"The Observer\">The Observer</a></i> sought help raising \u00a3200,000 to have his 4-year-old niece, who was diagnosed with <a href=\"/wiki/Glioma\" title=\"Glioma\">glioma</a>, treated at the Burzynski Clinic.<sup id=\"cite_ref-63\" class=\"reference\"><a href=\"#cite_note-63\">&#91;63&#93;</a></sup> Several bloggers reported other cases of patients who had spent similar amounts of money on the treatment, and had died, and challenged the validity of Burzynski's treatments.<sup id=\"cite_ref-64\" class=\"reference\"><a href=\"#cite_note-64\">&#91;64&#93;</a></sup><sup id=\"cite_ref-65\" class=\"reference\"><a href=\"#cite_note-65\">&#91;65&#93;</a></sup> Marc Stephens, identifying himself as a representative of the Burzynski Clinic, sent emails accusing them of libel and demanding that coverage of Burzynski be removed from their sites.<sup id=\"cite_ref-66\" class=\"reference\"><a href=\"#cite_note-66\">&#91;66&#93;</a></sup> One of the bloggers who received threatening e-mails from Stephens was <a href=\"/wiki/Rhys_Morgan\" title=\"Rhys Morgan\">Rhys Morgan</a>,<sup id=\"cite_ref-67\" class=\"reference\"><a href=\"#cite_note-67\">&#91;67&#93;</a></sup><sup id=\"cite_ref-68\" class=\"reference\"><a href=\"#cite_note-68\">&#91;68&#93;</a></sup><sup id=\"cite_ref-69\" class=\"reference\"><a href=\"#cite_note-69\">&#91;69&#93;</a></sup><sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup> a 17-year-old <a href=\"/wiki/Sixth_form\" title=\"Sixth form\">sixth-form</a> student from Cardiff, Wales, at the time, previously noted for exposing the <a href=\"/wiki/Miracle_Mineral_Supplement\" title=\"Miracle Mineral Supplement\">Miracle Mineral Supplement</a>.<sup id=\"cite_ref-71\" class=\"reference\"><a href=\"#cite_note-71\">&#91;71&#93;</a></sup><sup id=\"cite_ref-72\" class=\"reference\"><a href=\"#cite_note-72\">&#91;72&#93;</a></sup> Another was Andy Lewis, a skeptic and publisher of the Quackometer blog.<sup id=\"cite_ref-73\" class=\"reference\"><a href=\"#cite_note-73\">&#91;73&#93;</a></sup><sup id=\"cite_ref-74\" class=\"reference\"><a href=\"#cite_note-74\">&#91;74&#93;</a></sup><sup id=\"cite_ref-75\" class=\"reference\"><a href=\"#cite_note-75\">&#91;75&#93;</a></sup>\n</p><p>Following the publicity fallout resulting from the legal threats made by Stephens against the bloggers, the Burzynski Clinic issued a press release on November 29, 2011 confirming that the Clinic had hired Stephens \"to provide <a href=\"/wiki/Search_engine_optimization\" title=\"Search engine optimization\">web optimization</a> services and to attempt to stop the dissemination of false and inaccurate information concerning Dr. Burzynski and the Clinic\",<sup id=\"cite_ref-76\" class=\"reference\"><a href=\"#cite_note-76\">&#91;76&#93;</a></sup> apologizing for comments made by Stephens to bloggers and for the posting of personal information, and announcing that Stephens \"no longer has a professional relationship with the Burzynski Clinic.\"\n</p><p>The story, including the threats against the bloggers, was covered by the <i><a href=\"/wiki/BMJ\" class=\"mw-redirect\" title=\"BMJ\">BMJ</a></i> (formerly the <i>British Medical Journal</i>). The chief clinician at <a href=\"/wiki/Cancer_Research_UK\" title=\"Cancer Research UK\">Cancer Research UK</a> expressed his concern at the treatment offered, and Andy Lewis of Quackometer and science writer <a href=\"/wiki/Simon_Singh\" title=\"Simon Singh\">Simon Singh</a>, who had previously been sued by the <a href=\"/wiki/British_Chiropractic_Association\" title=\"British Chiropractic Association\">British Chiropractic Association</a>, said that <a href=\"/wiki/English_defamation_law\" title=\"English defamation law\">English libel law</a> harms public discussion of science and medicine, and thus public health.<sup id=\"cite_ref-77\" class=\"reference\"><a href=\"#cite_note-77\">&#91;77&#93;</a></sup>\n</p><p>In an article in <a href=\"/wiki/Skeptical_Inquirer\" title=\"Skeptical Inquirer\">Skeptical Inquirer</a> published in March 2014, skeptic Robert Blaskiewicz chronicled the activities by skeptics to investigate and challenge Burzynski's claim of cancer treatments.  He claimed aggressive actions by Burzynski's supporters toward the critics, including contacting their employers, lodging complaints to state licensing boards and defamation.  Blaskiewicz pointedly indicated that, although Burzynski had dismissed Marc Stephens, his clinic has not retracted the warnings of the possibility of lawsuits against critics, that it is \"a threat that hangs over all of these activists every day\".<sup id=\"cite_ref-78\" class=\"reference\"><a href=\"#cite_note-78\">&#91;78&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Media_and_commentary\">Media and commentary</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=11\" title=\"Edit section: Media and commentary\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>In 2010, Eric Merola, an <a href=\"/wiki/Art_director\" title=\"Art director\">art director</a> of television commercials, released a film titled <i>Burzynski: Cancer is Serious Business</i>, that promotes the Clinic's claims and describes Burzynski's use of antineoplastons and his legal clashes with government agencies and regulators.<sup id=\"cite_ref-79\" class=\"reference\"><a href=\"#cite_note-79\">&#91;79&#93;</a></sup> In March 2013, Merola released a follow-up movie to <i>Cancer is Serious Business</i>.<sup id=\"cite_ref-CPT12_80-0\" class=\"reference\"><a href=\"#cite_note-CPT12-80\">&#91;80&#93;</a></sup> <i><a href=\"/wiki/The_Village_Voice\" title=\"The Village Voice\">The Village Voice</a></i> commented that the first movie \"violates every basic rule of ethical filmmaking\" and that by interviewing only Burzynski's supporters, the film's producer \"is either unusually credulous, or doesn't understand the difference between a documentary and an advertisement\".<sup id=\"cite_ref-81\" class=\"reference\"><a href=\"#cite_note-81\">&#91;81&#93;</a></sup> <i><a href=\"/wiki/Variety_(magazine)\" title=\"Variety (magazine)\">Variety</a></i> described the film as having the qualities of a \"paranoid <a href=\"/wiki/Conspiracy_theory\" title=\"Conspiracy theory\">conspiracy theory</a>\" and likened it to the <i><a href=\"/wiki/National_Enquirer\" title=\"National Enquirer\">National Enquirer</a></i>, adding that the film's explanatory diagrams are \"simplistic to the point of idiocy\". The <i>Variety</i> review concluded that \"despite its infotainment look, <i>Burzynski</i> ultimately proves convincing.\"<sup id=\"cite_ref-82\" class=\"reference\"><a href=\"#cite_note-82\">&#91;82&#93;</a></sup></li>\n<li>In April 2013, Burzynski received the <a href=\"/wiki/Pigasus_Award\" title=\"Pigasus Award\">Pigasus Award</a>, which is bestowed each <a href=\"/wiki/April_Fool%27s_Day\" class=\"mw-redirect\" title=\"April Fool&#39;s Day\">April Fool's Day</a> by the <a href=\"/wiki/James_Randi_Educational_Foundation\" title=\"James Randi Educational Foundation\">James Randi Educational Foundation (JREF)</a> to \"honor the five worst offenders who are intentionally or unintentionally peddling harmful paranormal and pseudoscientific nonsense.\"<sup id=\"cite_ref-pigasus_83-0\" class=\"reference\"><a href=\"#cite_note-pigasus-83\">&#91;83&#93;</a></sup> The Foundation cited as the basis for the award the high cost of antineoplaston treatments, the lack of controlled trials demonstrating efficacy, the lack of FDA approval on the treatments, the lack of published final results of any single clinical trial, and the existence of FDA warning letters concerning research method safety and possible rules violations impacting patient safety.</li>\n<li>In June 2013, the <a href=\"/wiki/BBC\" title=\"BBC\">BBC</a>'s <i><a href=\"/wiki/Panorama_(TV_series)\" title=\"Panorama (TV series)\">Panorama</a></i> explored Burzynski in a documentary titled <i>Curing cancer or 'selling hope' to the vulnerable?</i> and argued \"Burzynski exploits a legal loophole\" by treating patients with antineoplastons \"as part of a clinical trial, so the drug does not need a licence\" for twenty years.<sup id=\"cite_ref-84\" class=\"reference\"><a href=\"#cite_note-84\">&#91;84&#93;</a></sup><sup id=\"cite_ref-85\" class=\"reference\"><a href=\"#cite_note-85\">&#91;85&#93;</a></sup> The clinic complained to the <a href=\"/wiki/OFCOM\" class=\"mw-redirect\" title=\"OFCOM\">Office of Communications</a> (Ofcom) about the documentary, but the complaint was not upheld.<sup id=\"cite_ref-OFCOM_86-0\" class=\"reference\"><a href=\"#cite_note-OFCOM-86\">&#91;86&#93;</a></sup></li>\n<li>In November 2013, an investigative report in <i><a href=\"/wiki/USA_Today\" title=\"USA Today\">USA Today</a></i> by Liz Szabo accused Burzynski of selling \"false hope to families\" for years.<sup id=\"cite_ref-87\" class=\"reference\"><a href=\"#cite_note-87\">&#91;87&#93;</a></sup>  In an interview with Reporting on Health, Szabo said that her interest in reporting on Burzynski was sparked when she emailed him with questions asking for a response to a book critical of him, and received a legal warning letter from his attorneys in reply.<sup id=\"cite_ref-88\" class=\"reference\"><a href=\"#cite_note-88\">&#91;88&#93;</a></sup></li>\n<li>In August 2015, Burzynski was listed by the <a href=\"/wiki/Houston_Press\" title=\"Houston Press\">Houston Press</a> as number 8 on a list of <i>The 10 Most Embarrassing Houstonians</i> accusing him of being \"Truly an embarrassment to such a medical city where some of the best cancer medicine in the world is performed.\"<sup id=\"cite_ref-89\" class=\"reference\"><a href=\"#cite_note-89\">&#91;89&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=12\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Smith1992-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Smith1992_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Smith1992_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Smith, Murray E. G. (1992). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.2307/3341192\">\"The Burzynski Controversy in the United States and in Canada: A Comparative Case Study in the Sociology of Alternative Medicine\"</a>. <i>The Canadian Journal of Sociology</i>. <b>17</b> (2): 133. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2307/3341192\">10.2307/3341192</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Canadian+Journal+of+Sociology&amp;rft.atitle=The+Burzynski+Controversy+in+the+United+States+and+in+Canada%3A+A+Comparative+Case+Study+in+the+Sociology+of+Alternative+Medicine&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=133&amp;rft.date=1992&amp;rft_id=info%3Adoi%2F10.2307%2F3341192&amp;rft.aulast=Smith&amp;rft.aufirst=Murray+E.+G.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.2307%2F3341192&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-cjc-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cjc_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">\"Unproven Methods of Cancer Management &#8212; Antineoplastons\". <i>CA: A Cancer Journal for Clinicians</i>. <b>33</b> (1): 57\u201359. 1983. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/canjclin.33.1.57\">10.3322/canjclin.33.1.57</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/6401577\">6401577</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CA%3A+A+Cancer+Journal+for+Clinicians&amp;rft.atitle=Unproven+Methods+of+Cancer+Management+%26mdash%3B+Antineoplastons&amp;rft.volume=33&amp;rft.issue=1&amp;rft.pages=57-59&amp;rft.date=1983&amp;rft_id=info%3Adoi%2F10.3322%2Fcanjclin.33.1.57&amp;rft_id=info%3Apmid%2F6401577&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\">Smith, p. 136 \"he earned his Ph.D. in biochemistry with a thesis entitled 'Investigations on amino acids and peptides in blood serum of healthy people and patients with chronic renal insufficiency'.\"</span>\n</li>\n<li id=\"cite_note-BRI-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-BRI_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.burzynskiresearch.com\">\"Burzynski Research Institute Home Page\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 10,</span> 2007</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Burzynski+Research+Institute+Home+Page&amp;rft_id=http%3A%2F%2Fwww.burzynskiresearch.com&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-vickers-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-vickers_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-vickers_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vickers, A. (2004). <a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/doi/10.3322/canjclin.54.2.110/full\">\"Alternative Cancer Cures: 'Unproven' or 'Disproven'?\"</a>. <i>CA</i>. <b>54</b> (2): 110\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/canjclin.54.2.110\">10.3322/canjclin.54.2.110</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15061600\">15061600</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CA&amp;rft.atitle=Alternative+Cancer+Cures%3A+%27Unproven%27+or+%27Disproven%27%3F&amp;rft.volume=54&amp;rft.issue=2&amp;rft.pages=110-8&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.3322%2Fcanjclin.54.2.110&amp;rft_id=info%3Apmid%2F15061600&amp;rft.aulast=Vickers&amp;rft.aufirst=A.&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.3322%2Fcanjclin.54.2.110%2Ffull&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-rocco-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-rocco_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Di Rocco, C (December 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://download.springer.com/static/pdf/89/art%253A10.1007%252Fs00381-014-2513-5.pdf?auth66=1426352663_c9647b49945395eb0d2ac67f6443ee73&amp;ext=.pdf\">\"Main editor's comment to the paper: the response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Childs Nerv Syst</i>. Childs Nerv Syst (Springer). <b>30</b> (12): 2063. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00381-014-2513-5\">10.1007/s00381-014-2513-5</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25096071\">25096071</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Childs+Nerv+Syst&amp;rft.atitle=Main+editor%27s+comment+to+the+paper%3A+the+response+and+survival+of+children+with+recurrent+diffuse+intrinsic+pontine+glioma+based+on+phase+II+study+of+antineoplastons+A10+and+AS2-1+in+patients+with+brainstem+glioma.+Stanislaw+R.+Burzynski%2C+Tomasz+J.+Janicki%2C+Gregory+S.+Burzynski%2C+Ania+Marszalek.&amp;rft.volume=30&amp;rft.issue=12&amp;rft.pages=2063&amp;rft.date=2014-12&amp;rft_id=info%3Adoi%2F10.1007%2Fs00381-014-2513-5&amp;rft_id=info%3Apmid%2F25096071&amp;rft.aulast=Di+Rocco&amp;rft.aufirst=C&amp;rft_id=http%3A%2F%2Fdownload.springer.com%2Fstatic%2Fpdf%2F89%2Fart%25253A10.1007%25252Fs00381-014-2513-5.pdf%3Fauth66%3D1426352663_c9647b49945395eb0d2ac67f6443ee73%26ext%3D.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Blaskiewicz-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Blaskiewicz_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Blaskiewicz, Robert (24 July 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.brainlife.org/fulltext/2014/Blaskiewicz_R140822.pdf\">\"Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Childs Nerv Syst</i>. Childs Nerv Syst (Springer). <b>30</b>: 2067\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00381-014-2514-4\">10.1007/s00381-014-2514-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25146834\">25146834</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Childs+Nerv+Syst&amp;rft.atitle=Comment+to+the+paper%3A+The+response+and+survival+of+children+with+recurrent+diffuse+intrinsic+pontine+glioma+based+on+phase+II+study+of+antineoplastons+A10+and+AS2-1+in+patients+with+brainstem+glioma&amp;rft.volume=30&amp;rft.pages=2067-8&amp;rft.date=2014-07-24&amp;rft_id=info%3Adoi%2F10.1007%2Fs00381-014-2514-4&amp;rft_id=info%3Apmid%2F25146834&amp;rft.aulast=Blaskiewicz&amp;rft.aufirst=Robert&amp;rft_id=http%3A%2F%2Fwww.brainlife.org%2Ffulltext%2F2014%2FBlaskiewicz_R140822.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-HoustonPressFine-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-HoustonPressFine_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Malisow, Craig (2017-02-17). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.houstonpress.com/news/unorthodox-doc-stanislaw-burzynski-faces-360-000-fine-and-probation-9206755\">\"Unorthodox Doc Stanislaw Burzynski Faces $360,000 Fine and Probation\"</a>. <i><a href=\"/wiki/Houston_Press\" title=\"Houston Press\">Houston Press</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Houston+Press&amp;rft.atitle=Unorthodox+Doc+Stanislaw+Burzynski+Faces+%24360%2C000+Fine+and+Probation&amp;rft.date=2017-02-17&amp;rft.aulast=Malisow&amp;rft.aufirst=Craig&amp;rft_id=http%3A%2F%2Fwww.houstonpress.com%2Fnews%2Funorthodox-doc-stanislaw-burzynski-faces-360-000-fine-and-probation-9206755&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Block, Keith I. (2004). \"Antineoplastons and the Challenges of Research in Integrative Care\". <i>Integrative Cancer Therapies</i>. <b>3</b> (1): 3\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/1534735404263274\">10.1177/1534735404263274</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15035867\">15035867</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Integrative+Cancer+Therapies&amp;rft.atitle=Antineoplastons+and+the+Challenges+of+Research+in+Integrative+Care&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=3-4&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1177%2F1534735404263274&amp;rft_id=info%3Apmid%2F15035867&amp;rft.aulast=Block&amp;rft.aufirst=Keith+I.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Brownlee, Shannon; Cohen, Gary (1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usnews.com/usnews/news/articles/981005/archive_004873.htm\">\"Trials of a Cancer Doc: Experimental drugs and a 20-year fight with the FDA\"</a>. <i>US News &amp; World Report</i>. <b>125</b> (13): 28\u201330, 32, 35. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10186429\">10186429</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=US+News+%26+World+Report&amp;rft.atitle=Trials+of+a+Cancer+Doc%3A+Experimental+drugs+and+a+20-year+fight+with+the+FDA&amp;rft.volume=125&amp;rft.issue=13&amp;rft.pages=28-30%2C+32%2C+35&amp;rft.date=1998&amp;rft_id=info%3Apmid%2F10186429&amp;rft.aulast=Brownlee&amp;rft.aufirst=Shannon&amp;rft.au=Cohen%2C+Gary&amp;rft_id=https%3A%2F%2Fwww.usnews.com%2Fusnews%2Fnews%2Farticles%2F981005%2Farchive_004873.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NCIfaq-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NCIfaq_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NCIfaq_11-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">National Cancer Institute <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/Patient/page2\">Information for Patients: Antineoplastons (PDQ\u00ae): Questions and Answers About Antineoplastons</a> Updated: April 9, 2013. Page accessed March 14, 2015.</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">The Lancet (1997). \"Lessons from antineoplaston\". <i>Lancet</i>. <b>349</b> (9054): 741. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2897%2921011-1\">10.1016/S0140-6736(97)21011-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9091754\">9091754</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Lessons+from+antineoplaston&amp;rft.volume=349&amp;rft.issue=9054&amp;rft.pages=741&amp;rft.date=1997&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2897%2921011-1&amp;rft_id=info%3Apmid%2F9091754&amp;rft.au=The+Lancet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16484713-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid16484713_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid16484713_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Burzynski, S. R.; Janicki, T. J.; Weaver, R. A.; Burzynski, B. (2006). \"Targeted Therapy with Antineoplastons A10 and AS2-1 of High-Grade, Recurrent, and Progressive Brainstem Glioma\". <i>Integrative Cancer Therapies</i>. <b>5</b> (1): 40\u201347. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/1534735405285380\">10.1177/1534735405285380</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16484713\">16484713</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Integrative+Cancer+Therapies&amp;rft.atitle=Targeted+Therapy+with+Antineoplastons+A10+and+AS2-1+of+High-Grade%2C+Recurrent%2C+and+Progressive+Brainstem+Glioma&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=40-47&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1177%2F1534735405285380&amp;rft_id=info%3Apmid%2F16484713&amp;rft.aulast=Burzynski&amp;rft.aufirst=S.+R.&amp;rft.au=Janicki%2C+T.+J.&amp;rft.au=Weaver%2C+R.+A.&amp;rft.au=Burzynski%2C+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Burzy1986-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Burzy1986_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Burzy1986_14-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Burzynski, SR (1986). \"Antineoplastons: history of the research (I)\". <i>Drugs under experimental and clinical research</i>. <b>12</b> (Suppl 1): 1\u20139. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3527634\">3527634</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs+under+experimental+and+clinical+research&amp;rft.atitle=Antineoplastons%3A+history+of+the+research+%28I%29&amp;rft.volume=12&amp;rft.issue=Suppl+1&amp;rft.pages=1-9&amp;rft.date=1986&amp;rft_id=info%3Apmid%2F3527634&amp;rft.aulast=Burzynski&amp;rft.aufirst=SR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Marshall1994-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Marshall1994_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Marshall, Eliot (1994). \"The Politics of Alternative Medicine\". <i>Science</i>. <b>265</b> (5181): 2000\u20132002. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.8091220\">10.1126/science.8091220</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8091220\">8091220</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=The+Politics+of+Alternative+Medicine&amp;rft.volume=265&amp;rft.issue=5181&amp;rft.pages=2000-2002&amp;rft.date=1994&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.8091220&amp;rft_id=info%3Apmid%2F8091220&amp;rft.aulast=Marshall&amp;rft.aufirst=Eliot&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\">NCI Drug Dictionary, <a rel=\"nofollow\" class=\"external text\" href=\"http://cancer.gov/Templates/drugdictionary.aspx?searchTxt=antineoplaston\">Definitions of antineoplastons A10 and AS2-1</a></span>\n</li>\n<li id=\"cite_note-SBM1-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SBM1_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SBM1_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencebasedmedicine.org/index.php/stanislaw-burzynskis-personalized-gene-targeted-cancer-therapy/\">Dr. Stanislaw Burzynski's \"personalized gene-targeted cancer therapy\": Can he do what he claims for cancer?</a>, David Gorski, Science Based Medicine</span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\">David Gorski for Science-Based Medicine. December 12, 2011 <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencebasedmedicine.org/stanislaw-burzynski-antineoplastons-and-the-orphan-drug-sodium-phenyl-butyrate/\">Dr. Stanislaw Burzynski, antineoplastons, and the selling of an orphan drug as a cancer cure</a> Quote: \" it\u2019s not the concept of \"personalized gene-targeted therapy\" to which I object. It\u2019s how Burzynski does it and how he corrupts the very concept through his \"everything but the kitchen sink\" approach to throwing \"targeted\" therapies at cancer patients willy-nilly without a systematic rationale for picking them or, it seems, any concern for potential adverse reactions due to combining drugs that have not been tested adequately in combination.\"</span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\">Sharon Hill for The Skeptical Inquirer. January 10, 2014 <a rel=\"nofollow\" class=\"external text\" href=\"http://www.csicop.org/specialarticles/show/burzynski_clinic_a_scientifical_year_of_fail/\">Burzynski Clinic: A Scientifical Year Of Fail</a></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\">National Cancer Institute. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/healthprofessional/Page5#_47\">Information for Professionals: Antineoplastons (PDQ\u00ae): Human/Clinical Studies</a> Updated: April 9, 2013. Page accessed March 14, 2015.</span>\n</li>\n<li id=\"cite_note-NCIsummary-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NCIsummary_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NCIsummary_21-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">National Cancer Institute. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/healthprofessional/page7\">Information for Professionals: Antineoplastons (PDQ\u00ae): Summary of the Evidence</a> Updated: April 9, 2013. Page accessed March 14, 2015.</span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hammer, Mitchell R.; Jonas, Wayne B. (March 2004). \"Managing Social Conflict in Complementary and Alternative Medicine Research: The Case of Antineoplastons\". <i>Integrative Cancer Therapies</i>. <b>3</b> (1): 59\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/1534735404263448\">10.1177/1534735404263448</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Integrative+Cancer+Therapies&amp;rft.atitle=Managing+Social+Conflict+in+Complementary+and+Alternative+Medicine+Research%3A+The+Case+of+Antineoplastons&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=59-65&amp;rft.date=2004-03&amp;rft_id=info%3Adoi%2F10.1177%2F1534735404263448&amp;rft.aulast=Hammer&amp;rft.aufirst=Mitchell+R.&amp;rft.au=Jonas%2C+Wayne+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.csicop.org/si/show/stanislaw_burzynski_four_decades_of_an_unproven_cancer_cure/\">Four decades of an unproven cancer cure</a>, David Gorski, Skeptical Inquirer vol 38.2, April 2014, Center for Inquiry</span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.forbes.com/sites/peterlipson/2013/04/19/a-film-producer-a-cancer-doctor-and-their-critics/\">A Film Producer, A Cancer Doctor, And Their Critics</a>, Peter Lipson, Forbes, 2013-19-04</span>\n</li>\n<li id=\"cite_note-Jaffe-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Jaffe_25-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Jaffe, Richard (2008). <i>Galileo's Lawyer: Courtroom Battles in Alternative Health, Complementary Medicine and Experimental Treatments</i>. Houston, TX: Thumbs UP. p.&#160;107. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0980118308\" title=\"Special:BookSources/978-0980118308\">978-0980118308</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Galileo%27s+Lawyer%3A+Courtroom+Battles+in+Alternative+Health%2C+Complementary+Medicine+and+Experimental+Treatments&amp;rft.place=Houston%2C+TX&amp;rft.pages=107&amp;rft.pub=Thumbs+UP&amp;rft.date=2008&amp;rft.isbn=978-0980118308&amp;rft.aulast=Jaffe&amp;rft.aufirst=Richard&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-USA_Today-26\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-USA_Today_26-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-USA_Today_26-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-USA_Today_26-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-USA_Today_26-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Szabo, Liz (November 15, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/nation/2013/11/15/stanislaw-burzynski-cancer-controversy/2994561/\">\"Doctor accused of selling false hope to families\"</a>. <i>USA Today</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 15,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Doctor+accused+of+selling+false+hope+to+families&amp;rft.date=2013-11-15&amp;rft.aulast=Szabo&amp;rft.aufirst=Liz&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2013%2F11%2F15%2Fstanislaw-burzynski-cancer-controversy%2F2994561%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ACS1-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ACS1_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ACS1_27-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ACS1_27-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ACS1_27-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20100721031005/http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/PharmacologicalandBiologicalTreatment/antineoplaston-therapy\">\"Antineoplaston Therapy\"</a>. American Cancer Society. November 2008. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/pharmacologicalandbiologicaltreatment/antineoplaston-therapy\">the original</a> on July 21, 2010<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">September 5,</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Antineoplaston+Therapy&amp;rft.pub=American+Cancer+Society&amp;rft.date=2008-11&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2Ftreatment%2Ftreatmentsandsideeffects%2Fcomplementaryandalternativemedicine%2Fpharmacologicalandbiologicaltreatment%2Fantineoplaston-therapy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-cancer-uk-28\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cancer-uk_28-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cancer-uk_28-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://cancerhelp.cancerresearchuk.org/about-cancer/cancer-questions/what-is-antineoplaston-therapy\">\"What is antineoplaston therapy?\"</a>. <a href=\"/wiki/Cancer_Research_UK\" title=\"Cancer Research UK\">Cancer Research UK</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 25,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=What+is+antineoplaston+therapy%3F&amp;rft.pub=Cancer+Research+UK&amp;rft_id=http%3A%2F%2Fcancerhelp.cancerresearchuk.org%2Fabout-cancer%2Fcancer-questions%2Fwhat-is-antineoplaston-therapy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\">National Cancer Institute. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/healthprofessional/page1\">Information for Professionals: Antineoplastons (PDQ\u00ae): Overview</a> Updated: April 9, 2013. Page accessed March 14, 2015.</span>\n</li>\n<li id=\"cite_note-Antineoplastic1983-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Antineoplastic1983_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\"><a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/doi/10.3322/canjclin.33.1.57/pdf\">\"Antineoplastons\"</a>. <i>CA</i>. <b>33</b> (1): 57\u20139. 1983. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/canjclin.33.1.57\">10.3322/canjclin.33.1.57</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/6401577\">6401577</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CA&amp;rft.atitle=Antineoplastons&amp;rft.volume=33&amp;rft.issue=1&amp;rft.pages=57-9&amp;rft.date=1983&amp;rft_id=info%3Adoi%2F10.3322%2Fcanjclin.33.1.57&amp;rft_id=info%3Apmid%2F6401577&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.3322%2Fcanjclin.33.1.57%2Fpdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-langford1998-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-langford1998_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Langford, Terri (October 1, 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.highbeam.com/doc/1P1-19476338.html\">\"Oncologists criticize methods of controversial cancer treatment\"</a>. Associated Press.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Oncologists+criticize+methods+of+controversial+cancer+treatment&amp;rft.date=1998-10-01&amp;rft.aulast=Langford&amp;rft.aufirst=Terri&amp;rft_id=http%3A%2F%2Fwww.highbeam.com%2Fdoc%2F1P1-19476338.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/burzynski2.html\">\"The Antineoplaston Anomaly: How a Drug Was Used for Decades in Thousands of Patients, With No Safety, Efficacy Data\"</a>. <i>The Cancer Letter</i>. September 25, 1998<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">August 26,</span> 2012</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cancer+Letter&amp;rft.atitle=The+Antineoplaston+Anomaly%3A+How+a+Drug+Was+Used+for+Decades+in+Thousands+of+Patients%2C+With+No+Safety%2C+Efficacy+Data&amp;rft.date=1998-09-25&amp;rft_id=http%3A%2F%2Fwww.quackwatch.org%2F01QuackeryRelatedTopics%2FCancer%2Fburzynski2.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MSKCC-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MSKCC_33-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.mskcc.org/cancer-care/herb/antineoplastons\">Antineoplastons</a>, <a href=\"/wiki/Memorial_Sloan-Kettering_Cancer_Center\" class=\"mw-redirect\" title=\"Memorial Sloan-Kettering Cancer Center\">Memorial Sloan-Kettering Cancer Center</a></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\">Burzynski Clinic <a rel=\"nofollow\" class=\"external text\" href=\"http://www.burzynskiclinic.com/preparing-for-your-appointment.html\">Preparing for your appointment</a> Page accessed March 15, 2014</span>\n</li>\n<li id=\"cite_note-opinion-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-opinion_35-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.3rdcoa.courts.state.tx.us/opinions/HTMLopinion.asp?OpinionID=847\">Texas State Board of Medical Examiners, Appellant v. Stanislaw R. Burzynski, M.D., Ph.D., Appellee</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110928111650/http://www.3rdcoa.courts.state.tx.us/opinions/HTMLopinion.asp?OpinionID=847\">Archived</a> September 28, 2011, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>. Court judgement</span>\n</li>\n<li id=\"cite_note-openjurist1987-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-openjurist1987_36-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://openjurist.org/819/f2d/1301/united-states-v-burzynski-cancer-research-institute-r\">819 F.2d 1301</a> 1987 judgment</span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2009/ucm192711.htm\">\"2009 Burzynski Research Institute Warning Letter\"</a>. U.S. Food and Drug Administration<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 22,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=2009+Burzynski+Research+Institute+Warning+Letter&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FICECI%2FEnforcementActions%2FWarningLetters%2F2009%2Fucm192711.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://scienceblogs.com/insolence/2012/11/07/stanislaw-burzynski-slapped-down-by-the-fda-once-again/\">Respectful Insolence</a>, ScienceBlogs, November 7, 2012</span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Szabo, Liz (December 11, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/nation/2013/12/11/fda-issues-warning-to-controversial-houston-cancer-doctor/3990623/\">\"FDA issues warning to controversial Houston cancer doctor\"</a>. <i><a href=\"/wiki/USA_Today\" title=\"USA Today\">USA Today</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 14,</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=FDA+issues+warning+to+controversial+Houston+cancer+doctor&amp;rft.date=2013-12-11&amp;rft.au=Szabo%2C+Liz&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2013%2F12%2F11%2Ffda-issues-warning-to-controversial-houston-cancer-doctor%2F3990623%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Lipson, Peter. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.forbes.com/sites/peterlipson/2013/11/11/fda-documents-paint-disturbing-picture-of-burzynski-cancer-clinic/\">\"FDA Documents Paint Disturbing Picture of Burzynski Cancer Clinic\"</a>. <a href=\"/wiki/Forbes\" title=\"Forbes\">Forbes</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 14,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=FDA+Documents+Paint+Disturbing+Picture+of+Burzynski+Cancer+Clinic&amp;rft.aulast=Lipson&amp;rft.aufirst=Peter&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fpeterlipson%2F2013%2F11%2F11%2Ffda-documents-paint-disturbing-picture-of-burzynski-cancer-clinic%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Gorski, David. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencebasedmedicine.org/revealed-by-the-fda-the-results-of-the-most-recent-inspection-of-the-burzynski-clinic/\">\"Revealed by the FDA: The results of the most recent inspection of the Burzynski Clinic\"</a>. Science Based Medicine<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 14,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Revealed+by+the+FDA%3A+The+results+of+the+most+recent+inspection+of+the+Burzynski+Clinic&amp;rft.pub=Science+Based+Medicine&amp;rft.aulast=Gorski&amp;rft.aufirst=David&amp;rft_id=http%3A%2F%2Fwww.sciencebasedmedicine.org%2Frevealed-by-the-fda-the-results-of-the-most-recent-inspection-of-the-burzynski-clinic%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM373967.pdf\">FDA Inspection Letter</a></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Szabo, Liz (December 11, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/nation/2013/12/11/fda-issues-warning-to-controversial-houston-cancer-doctor/3990623/\">\"FDA issues warning to controversial Houston cancer doctor\"</a>. <i><a href=\"/wiki/USA_Today\" title=\"USA Today\">USA Today</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 12,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=FDA+issues+warning+to+controversial+Houston+cancer+doctor&amp;rft.date=2013-12-11&amp;rft.au=Szabo%2C+Liz&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2013%2F12%2F11%2Ffda-issues-warning-to-controversial-houston-cancer-doctor%2F3990623%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm378237.htm\">\"Inspections, Compliance, Enforcement, and Criminal Investigations\"</a>. FDA<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 12,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Inspections%2C+Compliance%2C+Enforcement%2C+and+Criminal+Investigations&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FICECI%2FEnforcementActions%2FWarningLetters%2F2013%2Fucm378237.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-USA_Today_FDA_agrees-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-USA_Today_FDA_agrees_45-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Szabo, Liz (March 21, 2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/nation/2014/03/21/burzynski-cancer-patients-fda-drug/6711697/\">\"FDA agrees to let patients get controversial drug\"</a>. <i>USA Today</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=FDA+agrees+to+let+patients+get+controversial+drug&amp;rft.date=2014-03-21&amp;rft.aulast=Szabo&amp;rft.aufirst=Liz&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2014%2F03%2F21%2Fburzynski-cancer-patients-fda-drug%2F6711697%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4decs-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4decs_46-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\"><a href=\"/wiki/David_Gorski\" title=\"David Gorski\">Gorski D</a> (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.csicop.org/si/show/stanislaw_burzynski_four_decades_of_an_unproven_cancer_cure\">\"Stanislaw Burzynski: four decades of an unproven cancer cure\"</a>. <i>Skeptical Inquirer</i>. <b>38</b> (2): 36.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Skeptical+Inquirer&amp;rft.atitle=Stanislaw+Burzynski%3A+four+decades+of+an+unproven+cancer+cure&amp;rft.volume=38&amp;rft.issue=2&amp;rft.pages=36&amp;rft.date=2014&amp;rft.au=Gorski+D&amp;rft_id=http%3A%2F%2Fwww.csicop.org%2Fsi%2Fshow%2Fstanislaw_burzynski_four_decades_of_an_unproven_cancer_cure&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-statnews-2016-47\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-statnews-2016_47-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-statnews-2016_47-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-statnews-2016_47-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-statnews-2016_47-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Kaplan, Sheila (August 29, 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2016/08/29/stanislaw-burzynski-cancer-treatment-congress/\">\"To help cancer patients, lawmakers pushed access to a controversial doctor\"</a>. <i>STAT News</i>. <a href=\"/wiki/Boston_Globe_Media\" class=\"mw-redirect\" title=\"Boston Globe Media\">Boston Globe Media</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=STAT+News&amp;rft.atitle=To+help+cancer+patients%2C+lawmakers+pushed+access+to+a+controversial+doctor&amp;rft.date=2016-08-29&amp;rft.aulast=Kaplan&amp;rft.aufirst=Sheila&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2016%2F08%2F29%2Fstanislaw-burzynski-cancer-treatment-congress%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-tmb-2014-48\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-tmb-2014_48-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-tmb-2014_48-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-tmb-2014_48-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-tmb-2014_48-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/embeds/234000288/content\"><i>Hearing Conducted by the Texas State Office of Administrative hearings</i></a>, Texas Medical Board, July 10, 2014</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Hearing+Conducted+by+the+Texas+State+Office+of+Administrative+hearings&amp;rft.pub=Texas+Medical+Board&amp;rft.date=2014-07-10&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fembeds%2F234000288%2Fcontent&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> SOAH Docket No. 503-12-1342</span>\n</li>\n<li id=\"cite_note-brooks-2014-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-brooks-2014_49-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Brooks, David (July 14, 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nashuatelegraph.com/granitegeek/1041667-468/texas-medical-board-files-202-page-complain-against.html\">\"Texas Medical Board files 202-page complaint against cancer \"cure\" being used in NH\"</a>. <i>Nashua Telegraph</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">July 20,</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nashua+Telegraph&amp;rft.atitle=Texas+Medical+Board+files+202-page+complaint+against+cancer+%22cure%22+being+used+in+NH&amp;rft.date=2014-07-14&amp;rft.aulast=Brooks&amp;rft.aufirst=David&amp;rft_id=http%3A%2F%2Fwww.nashuatelegraph.com%2Fgranitegeek%2F1041667-468%2Ftexas-medical-board-files-202-page-complain-against.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-szabo-July2014-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-szabo-July2014_50-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Szabo, Liz (July 24, 2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/nation/2014/07/24/new-charges-for-burzynski/13111483/\">\"Texas medical board charges controversial cancer doctor\"</a>. USA Today<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">July 24,</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Texas+medical+board+charges+controversial+cancer+doctor&amp;rft.date=2014-07-24&amp;rft.aulast=Szabo&amp;rft.aufirst=Liz&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2014%2F07%2F24%2Fnew-charges-for-burzynski%2F13111483%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-51\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/288010171/Order-No-26-Finding-Mandatory-Basis-for-Attorney-Withdrawal\"><i>Order no. 26 - Finding mandatory basis for attorney withdrawal</i></a>, [Texas] State Office of Administrative Hearings, August 26, 2015</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Order+no.+26+-+Finding+mandatory+basis+for+attorney+withdrawal&amp;rft.pub=%5BTexas%5D+State+Office+of+Administrative+Hearings&amp;rft.date=2015-08-26&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F288010171%2FOrder-No-26-Finding-Mandatory-Basis-for-Attorney-Withdrawal&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> SOAH Docket No. 503-14-1342.MD</span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/288010206/Board-Staff-Response-to-Respondent-s-Motion-for-Continuance-of-Hearing-on-the-Merits-and-to-Modify-Order-No-27\"><i>Board staff response to respondent's motion for continuance of hearing on the merits and to modify order no. 27</i></a>, State Office of Administrative Hearings, October 23, 2015</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Board+staff+response+to+respondent%27s+motion+for+continuance+of+hearing+on+the+merits+and+to+modify+order+no.+27&amp;rft.pub=State+Office+of+Administrative+Hearings&amp;rft.date=2015-10-23&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F288010206%2FBoard-Staff-Response-to-Respondent-s-Motion-for-Continuance-of-Hearing-on-the-Merits-and-to-Modify-Order-No-27&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> SOAH Docket No. 503-14-1342.MD</span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/288010191/Order-No-27-Summarizing-August-26-2015-Prehearing-Conference-and-Modifying-the-Dates-for-the-hearing-on-the-Merits\"><i>Order no. 27 - Summarizing August 26. 2015 prehearing conference and modifying the dates for the hearing on the merits</i></a>, [Texas] State Office of Administrative Hearings, September 2, 2015</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Order+no.+27+-+Summarizing+August+26.+2015+prehearing+conference+and+modifying+the+dates+for+the+hearing+on+the+merits&amp;rft.pub=%5BTexas%5D+State+Office+of+Administrative+Hearings&amp;rft.date=2015-09-02&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F288010191%2FOrder-No-27-Summarizing-August-26-2015-Prehearing-Conference-and-Modifying-the-Dates-for-the-hearing-on-the-Merits&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> SOAH Docket No. 503-14-1342.MD</span>\n</li>\n<li id=\"cite_note-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-54\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Szabo, Liz (19 November 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/2015/11/19/controversial-texas-doctor-stanislaw-burzynski-goes-before-disciplinary-board/76006572/\">\"Controversial Texas doctor Stanislaw Burzynski goes before disciplinary board\"</a>. <i>USA Today</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">29 November</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Controversial+Texas+doctor+Stanislaw+Burzynski+goes+before+disciplinary+board&amp;rft.date=2015-11-19&amp;rft.aulast=Szabo&amp;rft.aufirst=Liz&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2F2015%2F11%2F19%2Fcontroversial-texas-doctor-stanislaw-burzynski-goes-before-disciplinary-board%2F76006572%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Chang2017a-55\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Chang2017a_55-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Chang2017a_55-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Chang, Julie (3 March 2017). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mystatesman.com/news/texas-medical-board-sanctions-controversial-cancer-doctor-burzynski/L9lDsfNTbBOuaWWqLEDBUI/\">\"Texas Medical Board sanctions controversial cancer doctor Burzynski\"</a>. <i><a href=\"/wiki/Austin_American-Statesman\" title=\"Austin American-Statesman\">Austin American-Statesman</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 April</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Austin+American-Statesman&amp;rft.atitle=Texas+Medical+Board+sanctions+controversial+cancer+doctor+Burzynski&amp;rft.date=2017-03-03&amp;rft.aulast=Chang&amp;rft.aufirst=Julie&amp;rft_id=http%3A%2F%2Fwww.mystatesman.com%2Fnews%2Ftexas-medical-board-sanctions-controversial-cancer-doctor-burzynski%2FL9lDsfNTbBOuaWWqLEDBUI%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-56\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Blaskiewicz, Robert (2017). \"Burzynski Sanctioned by Texas Medical Board\". <i><a href=\"/wiki/Skeptical_Inquirer\" title=\"Skeptical Inquirer\">Skeptical Inquirer</a></i>. <b>41</b> (4): 7\u20138.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Skeptical+Inquirer&amp;rft.atitle=Burzynski+Sanctioned+by+Texas+Medical+Board&amp;rft.volume=41&amp;rft.issue=4&amp;rft.pages=7-8&amp;rft.date=2017&amp;rft.aulast=Blaskiewicz&amp;rft.aufirst=Robert&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-TMBproposedJudgement-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-TMBproposedJudgement_57-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Texas Medical Board (15 February 2017). <a rel=\"nofollow\" class=\"external text\" href=\"http://images.houstonpress.com/media/pdf/232_final_order.pdf\">\"In the Matter of the Complaint Against Stanislaw Rajmund Burzynski, M.D. SOAH Docket No, 503-14-1342,MD\"</a> <span style=\"font-size:85%;\">(PDF)</span><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 April</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=In+the+Matter+of+the+Complaint+Against+Stanislaw+Rajmund+Burzynski%2C+M.D.+SOAH+Docket+No%2C+503-14-1342%2CMD&amp;rft.date=2017-02-15&amp;rft.au=Texas+Medical+Board&amp;rft_id=http%3A%2F%2Fimages.houstonpress.com%2Fmedia%2Fpdf%2F232_final_order.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Chang2017b-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Chang2017b_58-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Chang, Julie (3 March 2017). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.statesman.com/news/texas-medical-board-sanctions-controversial-cancer-doctor-burzynski/sxUP7GZ8XbYR4KzPTH5aCJ/\">\"Texas Medical Board sanctions controversial cancer doctor Burzynski\"</a>. <i><a href=\"/wiki/Austin_American-Statesman\" title=\"Austin American-Statesman\">Austin American-Statesman</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 April</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Austin+American-Statesman&amp;rft.atitle=Texas+Medical+Board+sanctions+controversial+cancer+doctor+Burzynski&amp;rft.date=2017-03-03&amp;rft.aulast=Chang&amp;rft.aufirst=Julie&amp;rft_id=http%3A%2F%2Fwww.statesman.com%2Fnews%2Ftexas-medical-board-sanctions-controversial-cancer-doctor-burzynski%2FsxUP7GZ8XbYR4KzPTH5aCJ%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MaxwellMayo-59\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MaxwellMayo_59-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MaxwellMayo_59-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Larry A. \"Max\" Maxwell &amp; Thomas Win. Mayo, <a rel=\"nofollow\" class=\"external text\" href=\"https://scholar.smu.edu/cgi/viewcontent.cgi?article=1600&amp;context=smulr\">Health Care Law</a>, <i>SMU Law Review</i>, Vol. 50, issue 2 (Annual Survey of Texas Law), pp. 1291-92.</span>\n</li>\n<li id=\"cite_note-TexasMedBoard-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-TexasMedBoard_60-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.ministryoftruth.me.uk/wp-content/uploads/2011/11/tmbvsburzynski.pdf\">http://www.ministryoftruth.me.uk/wp-content/uploads/2011/11/tmbvsburzynski.pdf</a></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\">Texas State Office of Administrative Hearings via <a rel=\"nofollow\" class=\"external text\" href=\"http://scienceblogs.com/insolence/2012/11/26/significance-of-the-tmb-dismissal-case-against-burzynski/\">Stanislaw Burzynski gets off on a technicality</a>, <a href=\"/wiki/National_Geographic_Society\" title=\"National Geographic Society\">National Geographic</a> ScienceBlogs</span>\n</li>\n<li id=\"cite_note-Langford-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Langford_62-0\">^</a></b></span> <span class=\"reference-text\">Cameron Langford. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.courthousenews.com/2012/01/19/43165.htm\">\"Cancer Patient Says Doc Used Her as ATM.\"</a> <i><a href=\"/wiki/Courthouse_News_Service\" title=\"Courthouse News Service\">Courthouse News Service</a></i>, January 19, 2012</span>\n</li>\n<li id=\"cite_note-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-63\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Luke Bainbridge (November 20, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/theobserver/2011/nov/20/a-family-gripped-by-cancer?INTCMP=SRCH\">\"<span style=\"padding-left:0.2em;\">\"</span>The worst year of my life: cancer has my family in its grip\" Luke Bainbridge. 20 November 2011\"</a>. London: Guardian<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">July 19,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%22The+worst+year+of+my+life%3A+cancer+has+my+family+in+its+grip%22+Luke+Bainbridge.+20+November+2011&amp;rft.date=2011-11-20&amp;rft.au=Luke+Bainbridge&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Ftheobserver%2F2011%2Fnov%2F20%2Fa-family-gripped-by-cancer%3FINTCMP%3DSRCH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://skepticalhumanities.com/2011/11/26/stanislaw-burzynskis-public-record/\">Stanislaw Burzynski's public record</a>, Skeptical Humanities</span>\n</li>\n<li id=\"cite_note-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-65\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://freethoughtblogs.com/pharyngula/2011/11/28/burzynski-clinic-the-domain-of-scoundrels-and-quacks/\">Burzynski clinic the domain of scoundrels and quacks</a>, <i>Pharyngula</i> (<a href=\"/wiki/PZ_Myers\" title=\"PZ Myers\">PZ Myers</a>)</span>\n</li>\n<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.skepticnorth.com/2011/11/burzynski-clinic-meet-the-streisand-effect/\">\"Burzynski Clinic? Meet the Streisand Effect\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 28,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Burzynski+Clinic%3F+Meet+the+Streisand+Effect&amp;rft_id=http%3A%2F%2Fwww.skepticnorth.com%2F2011%2F11%2Fburzynski-clinic-meet-the-streisand-effect%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-67\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Sample, Ian (November 29, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/world/2011/nov/29/schoolboy-blogger-us-clinic\">\"The schoolboy blogger who took on a US clinic\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>. London<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 29,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=The+schoolboy+blogger+who+took+on+a+US+clinic&amp;rft.date=2011-11-29&amp;rft.aulast=Sample&amp;rft.aufirst=Ian&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fworld%2F2011%2Fnov%2F29%2Fschoolboy-blogger-us-clinic&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-68\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Malisow, Craig (November 29, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://blogs.houstonpress.com/hairballs/2011/11/burzynski_fanatic_threatens_bloggers.php\">\"Burzynski Fanatic Threatens Bloggers 'Round the World\"</a>. <i><a href=\"/wiki/Houston_Press\" title=\"Houston Press\">Houston Press</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 29,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Houston+Press&amp;rft.atitle=Burzynski+Fanatic+Threatens+Bloggers+%27Round+the+World&amp;rft.date=2011-11-29&amp;rft.aulast=Malisow&amp;rft.aufirst=Craig&amp;rft_id=http%3A%2F%2Fblogs.houstonpress.com%2Fhairballs%2F2011%2F11%2Fburzynski_fanatic_threatens_bloggers.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-69\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Plait, Phil (November 28, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://blogs.discovermagazine.com/badastronomy/2011/11/28/alternative-cancer-clinic-threatens-to-sue-high-school-blogger/\">\"<span style=\"padding-left:0.2em;\">\"</span>Alternative\" cancer clinic threatens to sue high school blogger\"</a>. <i><a href=\"/wiki/Discover_Magazine\" class=\"mw-redirect\" title=\"Discover Magazine\">Discover Magazine</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 29,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Discover+Magazine&amp;rft.atitle=%22Alternative%22+cancer+clinic+threatens+to+sue+high+school+blogger&amp;rft.date=2011-11-28&amp;rft.aulast=Plait&amp;rft.aufirst=Phil&amp;rft_id=http%3A%2F%2Fblogs.discovermagazine.com%2Fbadastronomy%2F2011%2F11%2F28%2Falternative-cancer-clinic-threatens-to-sue-high-school-blogger%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Morgan, Rhys (November 20, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/commentisfree/cifamerica/2011/nov/30/burzynski-clinic-cancer-libel-laws\">\"The Burzynski Clinic is using libel laws to silence critics of its cancer treatment\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>. London<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 20,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=The+Burzynski+Clinic+is+using+libel+laws+to+silence+critics+of+its+cancer+treatment&amp;rft.date=2011-11-20&amp;rft.aulast=Morgan&amp;rft.aufirst=Rhys&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fcommentisfree%2Fcifamerica%2F2011%2Fnov%2F30%2Fburzynski-clinic-cancer-libel-laws&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Robbins, Martin (September 15, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/science/2010/sep/15/miracle-mineral-solutions-mms-bleach\">\"The man who encourages the sick and dying to drink industrial bleach\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>. London<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 1,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=The+man+who+encourages+the+sick+and+dying+to+drink+industrial+bleach&amp;rft.date=2010-09-15&amp;rft.aulast=Robbins&amp;rft.aufirst=Martin&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fscience%2F2010%2Fsep%2F15%2Fmiracle-mineral-solutions-mms-bleach&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-72\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-72\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120401213135/http://richarddawkins.net/articles/534614-praise-for-rhys-morgan-15-over-miracle-cure-alert\">\"The man who encourages the sick and dying to drink industrial bleach\"</a>. <i><a href=\"/wiki/The_Richard_Dawkins_Foundation_for_Reason_and_Science\" class=\"mw-redirect\" title=\"The Richard Dawkins Foundation for Reason and Science\">The Richard Dawkins Foundation for Reason and Science</a></i>. October 17, 2010. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://richarddawkins.net/articles/534614-praise-for-rhys-morgan-15-over-miracle-cure-alert\">the original</a> on April 1, 2012<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 1,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Richard+Dawkins+Foundation+for+Reason+and+Science&amp;rft.atitle=The+man+who+encourages+the+sick+and+dying+to+drink+industrial+bleach&amp;rft.date=2010-10-17&amp;rft_id=http%3A%2F%2Fricharddawkins.net%2Farticles%2F534614-praise-for-rhys-morgan-15-over-miracle-cure-alert&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-73\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://theness.com/neurologicablog/index.php/the-burzynski-clinic-another-crank-tries-to-intimidate-a-blogger/\">The Burzynski clinic: another crank tries to intimidate a blogger</a>, <a href=\"/wiki/Steve_Novella\" class=\"mw-redirect\" title=\"Steve Novella\">Steve Novella</a></span>\n</li>\n<li id=\"cite_note-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-74\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://rhysmorgan.co/2011/11/threats-from-the-burzynski-clinic/\">\"Threats From The Burzynski Clinic\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Threats+From+The+Burzynski+Clinic&amp;rft_id=http%3A%2F%2Frhysmorgan.co%2F2011%2F11%2Fthreats-from-the-burzynski-clinic%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-75\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-75\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.quackometer.net/blog/2011/11/the-burzynski-clinic-threatens-my-family.html\">Burzynski clinic threatens my family</a>, The Quackometer</span>\n</li>\n<li id=\"cite_note-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-76\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://docs.google.com/viewer?a=v&amp;pid=explorer&amp;chrome=true&amp;srcid=0BzijOpjuex1bMjE4N2JjOGItZGFlOS00NDE0LTk2YzktMThkYjFiOTU2YjNl&amp;hl=en_US\">\"Press Release\"</a>. Burzynski Clinic<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 29,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Press+Release&amp;rft.pub=Burzynski+Clinic&amp;rft_id=https%3A%2F%2Fdocs.google.com%2Fviewer%3Fa%3Dv%26pid%3Dexplorer%26chrome%3Dtrue%26srcid%3D0BzijOpjuex1bMjE4N2JjOGItZGFlOS00NDE0LTk2YzktMThkYjFiOTU2YjNl%26hl%3Den_US&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-77\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">McCartney, M. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bmj.com/content/343/bmj.d7865\">\"Texan clinic threatens UK bloggers with legal action over criticisms of its treatments\"</a>. <i>BMJ</i>. <b>343</b>: d7865. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/bmj.d7865\">10.1136/bmj.d7865</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22138837\">22138837</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Texan+clinic+threatens+UK+bloggers+with+legal+action+over+criticisms+of+its+treatments&amp;rft.volume=343&amp;rft.pages=d7865&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.d7865&amp;rft_id=info%3Apmid%2F22138837&amp;rft.aulast=McCartney&amp;rft.aufirst=M.&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcontent%2F343%2Fbmj.d7865&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Blaskiewicz, Robert (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.csicop.org/si/show/skeptic_activists_fighting_for_burzynskis_cancer_patients/\">\"Skeptic Activists Fighting for Burzynski's Cancer Patients\"</a>. <i>Skeptical Inquirer</i>. CSI. <b>38.2</b> (March/April): 44\u201347.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Skeptical+Inquirer&amp;rft.atitle=Skeptic+Activists+Fighting+for+Burzynski%E2%80%99s+Cancer+Patients&amp;rft.volume=38.2&amp;rft.issue=March%2FApril&amp;rft.pages=44-47&amp;rft.date=2014&amp;rft.aulast=Blaskiewicz&amp;rft.aufirst=Robert&amp;rft_id=http%3A%2F%2Fwww.csicop.org%2Fsi%2Fshow%2Fskeptic_activists_fighting_for_burzynskis_cancer_patients%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Catsoulis, Jeannette (June 4, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://movies.nytimes.com/2010/06/04/movies/04burzynski.html\">\"A Texas Doctor With a Possible Cancer Cure\"</a>. New York Times.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+Texas+Doctor+With+a+Possible+Cancer+Cure&amp;rft.date=2010-06-04&amp;rft.aulast=Catsoulis&amp;rft.aufirst=Jeannette&amp;rft_id=https%3A%2F%2Fmovies.nytimes.com%2F2010%2F06%2F04%2Fmovies%2F04burzynski.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.imdb.com/title/tt1632703/\"><i>Burzynski</i></a> on <a href=\"/wiki/IMDb\" title=\"IMDb\">IMDb</a>&#32;</span>\n</li>\n<li id=\"cite_note-CPT12-80\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-CPT12_80-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">IMDB (August 21, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.imdb.com/title/tt2908348/?ref_=nm_knf_i2\">\"Burzynski&lt; part II IMDB\"</a>. IMDB.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">August 29,</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Burzynski%3C+part+II+IMDB&amp;rft.date=2013-08-21&amp;rft.au=IMDB&amp;rft_id=https%3A%2F%2Fwww.imdb.com%2Ftitle%2Ftt2908348%2F%3Fref_%3Dnm_knf_i2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-81\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-81\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Ella Taylor (June 1, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.villagevoice.com/2010-06-01/film/quack-quack-goes-burzynski/\">\"QUACK-QUACK Goes Burzynski - Page 1 - Movies - New York\"</a>. Village Voice<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 25,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=QUACK-QUACK+Goes+Burzynski+-+Page+1+-+Movies+-+New+York&amp;rft.pub=Village+Voice&amp;rft.date=2010-06-01&amp;rft.au=Ella+Taylor&amp;rft_id=http%3A%2F%2Fwww.villagevoice.com%2F2010-06-01%2Ffilm%2Fquack-quack-goes-burzynski%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-82\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-82\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Scheib, Ronnie (June 3, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.variety.com/review/VE1117942914?refcatid=31\">\"Variety Reviews - Burzynski - Film Reviews - New U.S. Release - Review by Ronnie Scheib\"</a>. Variety.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 25,</span> 2011</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Variety+Reviews+-+Burzynski+-+Film+Reviews+-+New+U.S.+Release+-+Review+by+Ronnie+Scheib&amp;rft.date=2010-06-03&amp;rft.aulast=Scheib&amp;rft.aufirst=Ronnie&amp;rft_id=http%3A%2F%2Fwww.variety.com%2Freview%2FVE1117942914%3Frefcatid%3D31&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pigasus-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pigasus_83-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.randi.org/site/index.php/jref-news/2074-jrefs-pigasus-awards-to-honor-dubious-peddlers-of-woo.html\">\"JREF's Pigasus Awards \"Honors\" Dubious Peddlers of \"Woo<span style=\"padding-right:0.2em;\">\"</span>\"</a>. <a href=\"/wiki/James_Randi_Educational_Foundation\" title=\"James Randi Educational Foundation\">James Randi Educational Foundation</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 1,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=JREF%27s+Pigasus+Awards+%22Honors%22+Dubious+Peddlers+of+%22Woo%22&amp;rft.pub=James+Randi+Educational+Foundation&amp;rft_id=http%3A%2F%2Fwww.randi.org%2Fsite%2Findex.php%2Fjref-news%2F2074-jrefs-pigasus-awards-to-honor-dubious-peddlers-of-woo.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-84\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Richard Bilton (August 22, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.co.uk/news/health-22717245\">\"Curing cancer or 'selling hope' to the vulnerable?\"</a>. <a href=\"/wiki/Panorama_(TV_series)\" title=\"Panorama (TV series)\">Panorama (TV series)</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 June</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Curing+cancer+or+%27selling+hope%27+to+the+vulnerable%3F&amp;rft.date=2013-08-22&amp;rft.au=Richard+Bilton&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fhealth-22717245&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-85\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-85\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.getreading.co.uk/news/amelia-saunders-family-mislead-burzynski-4051287\">\"Amelia's family 'mislead by cancer clinic<span style=\"padding-right:0.2em;\">'</span>\"</a>. <a href=\"/wiki/Reading_Post\" title=\"Reading Post\">Reading Post</a>. August 22, 2013<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 June</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amelia%27s+family+%27mislead+by+cancer+clinic%27&amp;rft.pub=Reading+Post&amp;rft.date=2013-08-22&amp;rft_id=http%3A%2F%2Fwww.getreading.co.uk%2Fnews%2Famelia-saunders-family-mislead-burzynski-4051287&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-OFCOM-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-OFCOM_86-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"http://stakeholders.ofcom.org.uk/binaries/enforcement/broadcast-bulletins/243/obb243.pdf\">\"Complaint by Johnsons Solicitors on behalf of the Burzynski Clinic\"</a> <span style=\"font-size:85%;\">(PDF)</span>, <i>Ofcom Broadcast Bulletin</i> (Number 243), pp.&#160;23\u201335, December 2, 2013<span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">December 2,</span> 2013</span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ofcom+Broadcast+Bulletin&amp;rft.atitle=Complaint+by+Johnsons+Solicitors+on+behalf+of+the+Burzynski+Clinic&amp;rft.issue=Number+243&amp;rft.pages=23-35&amp;rft.date=2013-12-02&amp;rft_id=http%3A%2F%2Fstakeholders.ofcom.org.uk%2Fbinaries%2Fenforcement%2Fbroadcast-bulletins%2F243%2Fobb243.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-87\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Szabo, Liz (November 15, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/nation/2013/11/15/stanislaw-burzynski-cancer-controversy/2994561/\">\"Doctor accused of selling false hope to families\"</a>. <i><a href=\"/wiki/USA_Today\" title=\"USA Today\">USA Today</a></i>. Updated July 8, 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 12,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Doctor+accused+of+selling+false+hope+to+families&amp;rft.date=2013-11-15&amp;rft.au=Szabo%2C+Liz&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2013%2F11%2F15%2Fstanislaw-burzynski-cancer-controversy%2F2994561%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-88\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.reportingonhealth.org/2014/01/12/qa-liz-szabo-braving-legal-threats-investigate-medical-folk-hero\">\"Braving legal threats to investigate a medical folk hero\"</a>. Reporting on Health.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Braving+legal+threats+to+investigate+a+medical+folk+hero&amp;rft.pub=Reporting+on+Health&amp;rft_id=http%3A%2F%2Fwww.reportingonhealth.org%2F2014%2F01%2F12%2Fqa-liz-szabo-braving-legal-threats-investigate-medical-folk-hero&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-89\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-89\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.houstonpress.com/news/the-10-most-embarrassing-houstonians-7681068\">\"The 10 Most Embarrassing Houstonians\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 September</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+10+Most+Embarrassing+Houstonians&amp;rft_id=http%3A%2F%2Fwww.houstonpress.com%2Fnews%2Fthe-10-most-embarrassing-houstonians-7681068&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=13\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><cite class=\"citation web\"><a href=\"/wiki/David_Gorski\" title=\"David Gorski\">Gorski D</a> (14 March 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencebasedmedicine.org/burzynski-cancer-is-a-serious-business-part-2-like-the-first-burzynski-movie-only-more-so/\">\"Burzynski: Cancer Is A Serious Business, Part 2: Like the first Burzynski movie, only more so?\"</a>. Science-Based Medicine<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 March</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Burzynski%3A+Cancer+Is+A+Serious+Business%2C+Part+2%3A+Like+the+first+Burzynski+movie%2C+only+more+so%3F&amp;rft.pub=Science-Based+Medicine&amp;rft.date=2013-03-14&amp;rft.au=Gorski+D&amp;rft_id=http%3A%2F%2Fwww.sciencebasedmedicine.org%2Fburzynski-cancer-is-a-serious-business-part-2-like-the-first-burzynski-movie-only-more-so%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\">Green S (19 January 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/burzynski1.html\">\"Stanislaw Burzynski and 'Antineoplastons<span style=\"padding-right:0.2em;\">'</span>\"</a>. Quackwatch<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 March</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Stanislaw+Burzynski+and+%27Antineoplastons%27&amp;rft.pub=Quackwatch&amp;rft.date=2013-01-19&amp;rft.au=Green+S&amp;rft_id=http%3A%2F%2Fwww.quackwatch.org%2F01QuackeryRelatedTopics%2FCancer%2Fburzynski1.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABurzynski+Clinic\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Burzynski_Clinic&amp;action=edit&amp;section=14\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.burzynskiclinic.com\">Burzynski Clinic</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.sec.gov/Archives/edgar/data/724445/000110465911032257/a11-13213_110k.htm\">Burzynski Research Institute, Inc.</a> FORM 10-K For the fiscal year ended February 28, 2011. Legally-required financial statements and other filings with the Securities and Exchange Commission.</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2189\nCached time: 20180915214253\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.672 seconds\nReal time usage: 0.736 seconds\nPreprocessor visited node count: 3298/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 121414/2097152 bytes\nTemplate argument size: 2621/2097152 bytes\nHighest expansion depth: 13/40\nExpensive parser function count: 4/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 92513/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.338/10.000 seconds\nLua memory usage: 4.96 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  627.966      1 -total\n 74.58%  468.360      1 Template:Reflist\n 20.83%  130.831     27 Template:Cite_news\n 17.56%  110.267     17 Template:Cite_journal\n 11.67%   73.284     16 Template:Cite_web\n  6.36%   39.921      1 Template:Pp\n  3.98%   24.996      2 Template:Quotation\n  3.95%   24.774      1 Template:IMDb_title\n  3.36%   21.079      4 Template:Citation\n  2.32%   14.589      1 Template:Use_mdy_dates\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1018018-0!canonical and timestamp 20180915214253 and revision id 859721775\n -->\n</div>"},"langlinks":[{"lang":"it","url":"https://it.wikipedia.org/wiki/Clinica_Burzynski","langname":"Italian","autonym":"italiano","*":"Clinica Burzynski"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Burzynski_Clinic","langname":"Dutch","autonym":"Nederlands","*":"Burzynski Clinic"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Klinika_Burzy%C5%84skiego","langname":"Polish","autonym":"polski","*":"Klinika Burzy\u0144skiego"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Cl%C3%ADnica_Burzynski","langname":"Portuguese","autonym":"portugu\u00eas","*":"Cl\u00ednica Burzynski"}],"categories":[{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"Burzynski Clinic","hidden":"","*":"Wikipedia_indefinitely_semi-protected_pages"},{"sortkey":"Burzynski, Stanislaw","hidden":"","*":"Use_mdy_dates_from_December_2014"},{"sortkey":"Burzynski, Stanislaw","*":"Alternative_cancer_treatments"},{"sortkey":"Burzynski, Stanislaw","*":"Pseudoscience"},{"sortkey":"Burzynski, Stanislaw","*":"Clinics_in_the_United_States"},{"sortkey":"Burzynski, Stanislaw","*":"Health_fraud"},{"sortkey":"Burzynski, Stanislaw","*":"1976_establishments_in_Texas"},{"sortkey":"Burzynski, Stanislaw","*":"Medical_and_health_organizations_based_in_Texas"}],"links":[{"ns":4,"exists":"","*":"Wikipedia:Protection policy"},{"ns":14,"exists":"","*":"Category:Use mdy dates from December 2014"},{"ns":0,"exists":"","*":"Administrative law"},{"ns":0,"exists":"","*":"Administrative law judge"},{"ns":0,"exists":"","*":"Alternative cancer treatment"},{"ns":0,"exists":"","*":"American Cancer Society"},{"ns":0,"exists":"","*":"April Fool's Day"},{"ns":0,"exists":"","*":"Art director"},{"ns":0,"exists":"","*":"Austin American-Statesman"},{"ns":0,"exists":"","*":"BBC"},{"ns":0,"exists":"","*":"BMJ"},{"ns":0,"exists":"","*":"Bait-and-switch"},{"ns":0,"exists":"","*":"Baylor College of Medicine"},{"ns":0,"exists":"","*":"Boston Globe Media"},{"ns":0,"exists":"","*":"British Chiropractic Association"},{"ns":0,"exists":"","*":"Cancer Research UK"},{"ns":0,"exists":"","*":"Cancer treatment"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Conspiracy theory"},{"ns":0,"exists":"","*":"Courthouse News Service"},{"ns":0,"exists":"","*":"David Gorski"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Discover Magazine"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"English defamation law"},{"ns":0,"exists":"","*":"FDA Warning Letter"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Forbes"},{"ns":0,"exists":"","*":"Glioma"},{"ns":0,"exists":"","*":"Houston Press"},{"ns":0,"exists":"","*":"Human subject research"},{"ns":0,"exists":"","*":"IMDb"},{"ns":0,"exists":"","*":"Institutional Review Board"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Interstate commerce"},{"ns":0,"exists":"","*":"James Randi Educational Foundation"},{"ns":0,"exists":"","*":"Lublin"},{"ns":0,"exists":"","*":"Medical University of Lublin"},{"ns":0,"exists":"","*":"Memorial Sloan-Kettering Cancer Center"},{"ns":0,"exists":"","*":"Miracle Mineral Supplement"},{"ns":0,"exists":"","*":"National Cancer Institute"},{"ns":0,"exists":"","*":"National Enquirer"},{"ns":0,"exists":"","*":"National Geographic Society"},{"ns":0,"exists":"","*":"Neoplasm"},{"ns":0,"exists":"","*":"Neurotoxicity"},{"ns":0,"exists":"","*":"OFCOM"},{"ns":0,"exists":"","*":"Off-label use"},{"ns":0,"exists":"","*":"Oncology"},{"ns":0,"exists":"","*":"PZ Myers"},{"ns":0,"exists":"","*":"Panorama (TV series)"},{"ns":0,"exists":"","*":"Peptides"},{"ns":0,"exists":"","*":"Personalized medicine"},{"ns":0,"exists":"","*":"Phenylacetic acid"},{"ns":0,"exists":"","*":"Phenylacetylglutamine"},{"ns":0,"exists":"","*":"Pigasus Award"},{"ns":0,"exists":"","*":"Poland"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Randomized controlled trial"},{"ns":0,"exists":"","*":"Reading Post"},{"ns":0,"exists":"","*":"Reproducibility"},{"ns":0,"exists":"","*":"Rhys Morgan"},{"ns":0,"exists":"","*":"Scientific literature"},{"ns":0,"exists":"","*":"Search engine optimization"},{"ns":0,"exists":"","*":"Simon Singh"},{"ns":0,"exists":"","*":"Sixth form"},{"ns":0,"exists":"","*":"Skeptical Inquirer"},{"ns":0,"exists":"","*":"Steve Novella"},{"ns":0,"exists":"","*":"Targeted cancer therapy"},{"ns":0,"exists":"","*":"Texas"},{"ns":0,"exists":"","*":"Texas Attorney General"},{"ns":0,"exists":"","*":"Texas Court of Appeals"},{"ns":0,"exists":"","*":"Texas Medical Board"},{"ns":0,"exists":"","*":"Texas State Office of Administrative Hearings"},{"ns":0,"exists":"","*":"The Guardian"},{"ns":0,"exists":"","*":"The Observer"},{"ns":0,"exists":"","*":"The Richard Dawkins Foundation for Reason and Science"},{"ns":0,"exists":"","*":"The Village Voice"},{"ns":0,"exists":"","*":"USA Today"},{"ns":0,"exists":"","*":"United States"},{"ns":0,"exists":"","*":"Variety (magazine)"},{"ns":0,"exists":"","*":"Vicarious liability"},{"ns":0,"exists":"","*":"Wayback Machine"}],"templates":[{"ns":10,"exists":"","*":"Template:Pp"},{"ns":10,"exists":"","*":"Template:Use mdy dates"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Rp"},{"ns":10,"exists":"","*":"Template:For"},{"ns":10,"exists":"","*":"Template:Quotation"},{"ns":10,"exists":"","*":"Template:Quote"},{"ns":10,"exists":"","*":"Template:Quote/styles.css"},{"ns":10,"exists":"","*":"Template:Comma separated entries"},{"ns":10,"exists":"","*":"Template:If empty"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:IMDb title"},{"ns":10,"exists":"","*":"Template:Str left"},{"ns":10,"exists":"","*":"Template:Str len"},{"ns":10,"exists":"","*":"Template:Str rightmost"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":10,"exists":"","*":"Template:Cite"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Protection banner"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:File link"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Effective protection level"},{"ns":828,"exists":"","*":"Module:Effective protection expiry"},{"ns":828,"exists":"","*":"Module:Protection banner/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:For"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:If empty"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Padlock-silver.svg"],"externallinks":["https://dx.doi.org/10.2307/3341192","//doi.org/10.2307/3341192","//doi.org/10.3322/canjclin.33.1.57","//www.ncbi.nlm.nih.gov/pubmed/6401577","http://www.burzynskiresearch.com","http://onlinelibrary.wiley.com/doi/10.3322/canjclin.54.2.110/full","//doi.org/10.3322/canjclin.54.2.110","//www.ncbi.nlm.nih.gov/pubmed/15061600","http://download.springer.com/static/pdf/89/art%253A10.1007%252Fs00381-014-2513-5.pdf?auth66=1426352663_c9647b49945395eb0d2ac67f6443ee73&ext=.pdf","//doi.org/10.1007/s00381-014-2513-5","//www.ncbi.nlm.nih.gov/pubmed/25096071","http://www.brainlife.org/fulltext/2014/Blaskiewicz_R140822.pdf","//doi.org/10.1007/s00381-014-2514-4","//www.ncbi.nlm.nih.gov/pubmed/25146834","http://www.houstonpress.com/news/unorthodox-doc-stanislaw-burzynski-faces-360-000-fine-and-probation-9206755","//doi.org/10.1177/1534735404263274","//www.ncbi.nlm.nih.gov/pubmed/15035867","https://www.usnews.com/usnews/news/articles/981005/archive_004873.htm","//www.ncbi.nlm.nih.gov/pubmed/10186429","http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/Patient/page2","//doi.org/10.1016/S0140-6736(97)21011-1","//www.ncbi.nlm.nih.gov/pubmed/9091754","//doi.org/10.1177/1534735405285380","//www.ncbi.nlm.nih.gov/pubmed/16484713","//www.ncbi.nlm.nih.gov/pubmed/3527634","//doi.org/10.1126/science.8091220","//www.ncbi.nlm.nih.gov/pubmed/8091220","http://cancer.gov/Templates/drugdictionary.aspx?searchTxt=antineoplaston","http://www.sciencebasedmedicine.org/index.php/stanislaw-burzynskis-personalized-gene-targeted-cancer-therapy/","http://www.sciencebasedmedicine.org/stanislaw-burzynski-antineoplastons-and-the-orphan-drug-sodium-phenyl-butyrate/","http://www.csicop.org/specialarticles/show/burzynski_clinic_a_scientifical_year_of_fail/","http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/healthprofessional/Page5#_47","http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/healthprofessional/page7","//doi.org/10.1177/1534735404263448","http://www.csicop.org/si/show/stanislaw_burzynski_four_decades_of_an_unproven_cancer_cure/","https://www.forbes.com/sites/peterlipson/2013/04/19/a-film-producer-a-cancer-doctor-and-their-critics/","https://www.usatoday.com/story/news/nation/2013/11/15/stanislaw-burzynski-cancer-controversy/2994561/","https://web.archive.org/web/20100721031005/http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/PharmacologicalandBiologicalTreatment/antineoplaston-therapy","http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/pharmacologicalandbiologicaltreatment/antineoplaston-therapy","http://cancerhelp.cancerresearchuk.org/about-cancer/cancer-questions/what-is-antineoplaston-therapy","http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/healthprofessional/page1","http://onlinelibrary.wiley.com/doi/10.3322/canjclin.33.1.57/pdf","http://www.highbeam.com/doc/1P1-19476338.html","http://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/burzynski2.html","http://www.mskcc.org/cancer-care/herb/antineoplastons","http://www.burzynskiclinic.com/preparing-for-your-appointment.html","http://www.3rdcoa.courts.state.tx.us/opinions/HTMLopinion.asp?OpinionID=847","https://web.archive.org/web/20110928111650/http://www.3rdcoa.courts.state.tx.us/opinions/HTMLopinion.asp?OpinionID=847","http://openjurist.org/819/f2d/1301/united-states-v-burzynski-cancer-research-institute-r","http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2009/ucm192711.htm","http://scienceblogs.com/insolence/2012/11/07/stanislaw-burzynski-slapped-down-by-the-fda-once-again/","https://www.usatoday.com/story/news/nation/2013/12/11/fda-issues-warning-to-controversial-houston-cancer-doctor/3990623/","https://www.forbes.com/sites/peterlipson/2013/11/11/fda-documents-paint-disturbing-picture-of-burzynski-cancer-clinic/","http://www.sciencebasedmedicine.org/revealed-by-the-fda-the-results-of-the-most-recent-inspection-of-the-burzynski-clinic/","http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM373967.pdf","http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm378237.htm","https://www.usatoday.com/story/news/nation/2014/03/21/burzynski-cancer-patients-fda-drug/6711697/","http://www.csicop.org/si/show/stanislaw_burzynski_four_decades_of_an_unproven_cancer_cure","https://www.statnews.com/2016/08/29/stanislaw-burzynski-cancer-treatment-congress/","https://www.scribd.com/embeds/234000288/content","http://www.nashuatelegraph.com/granitegeek/1041667-468/texas-medical-board-files-202-page-complain-against.html","https://www.usatoday.com/story/news/nation/2014/07/24/new-charges-for-burzynski/13111483/","https://www.scribd.com/doc/288010171/Order-No-26-Finding-Mandatory-Basis-for-Attorney-Withdrawal","https://www.scribd.com/doc/288010206/Board-Staff-Response-to-Respondent-s-Motion-for-Continuance-of-Hearing-on-the-Merits-and-to-Modify-Order-No-27","https://www.scribd.com/doc/288010191/Order-No-27-Summarizing-August-26-2015-Prehearing-Conference-and-Modifying-the-Dates-for-the-hearing-on-the-Merits","https://www.usatoday.com/story/news/2015/11/19/controversial-texas-doctor-stanislaw-burzynski-goes-before-disciplinary-board/76006572/","http://www.mystatesman.com/news/texas-medical-board-sanctions-controversial-cancer-doctor-burzynski/L9lDsfNTbBOuaWWqLEDBUI/","http://images.houstonpress.com/media/pdf/232_final_order.pdf","http://www.statesman.com/news/texas-medical-board-sanctions-controversial-cancer-doctor-burzynski/sxUP7GZ8XbYR4KzPTH5aCJ/","https://scholar.smu.edu/cgi/viewcontent.cgi?article=1600&context=smulr","http://scienceblogs.com/insolence/2012/11/26/significance-of-the-tmb-dismissal-case-against-burzynski/","http://www.courthousenews.com/2012/01/19/43165.htm","https://www.theguardian.com/theobserver/2011/nov/20/a-family-gripped-by-cancer?INTCMP=SRCH","http://skepticalhumanities.com/2011/11/26/stanislaw-burzynskis-public-record/","http://freethoughtblogs.com/pharyngula/2011/11/28/burzynski-clinic-the-domain-of-scoundrels-and-quacks/","http://www.skepticnorth.com/2011/11/burzynski-clinic-meet-the-streisand-effect/","https://www.theguardian.com/world/2011/nov/29/schoolboy-blogger-us-clinic","http://blogs.houstonpress.com/hairballs/2011/11/burzynski_fanatic_threatens_bloggers.php","http://blogs.discovermagazine.com/badastronomy/2011/11/28/alternative-cancer-clinic-threatens-to-sue-high-school-blogger/","https://www.theguardian.com/commentisfree/cifamerica/2011/nov/30/burzynski-clinic-cancer-libel-laws","https://www.theguardian.com/science/2010/sep/15/miracle-mineral-solutions-mms-bleach","https://web.archive.org/web/20120401213135/http://richarddawkins.net/articles/534614-praise-for-rhys-morgan-15-over-miracle-cure-alert","http://richarddawkins.net/articles/534614-praise-for-rhys-morgan-15-over-miracle-cure-alert","http://theness.com/neurologicablog/index.php/the-burzynski-clinic-another-crank-tries-to-intimidate-a-blogger/","http://rhysmorgan.co/2011/11/threats-from-the-burzynski-clinic/","http://www.quackometer.net/blog/2011/11/the-burzynski-clinic-threatens-my-family.html","https://docs.google.com/viewer?a=v&pid=explorer&chrome=true&srcid=0BzijOpjuex1bMjE4N2JjOGItZGFlOS00NDE0LTk2YzktMThkYjFiOTU2YjNl&hl=en_US","http://www.bmj.com/content/343/bmj.d7865","//doi.org/10.1136/bmj.d7865","//www.ncbi.nlm.nih.gov/pubmed/22138837","http://www.csicop.org/si/show/skeptic_activists_fighting_for_burzynskis_cancer_patients/","https://movies.nytimes.com/2010/06/04/movies/04burzynski.html","https://www.imdb.com/title/tt1632703/","https://www.imdb.com/title/tt2908348/?ref_=nm_knf_i2","http://www.villagevoice.com/2010-06-01/film/quack-quack-goes-burzynski/","http://www.variety.com/review/VE1117942914?refcatid=31","http://www.randi.org/site/index.php/jref-news/2074-jrefs-pigasus-awards-to-honor-dubious-peddlers-of-woo.html","https://www.bbc.co.uk/news/health-22717245","http://www.getreading.co.uk/news/amelia-saunders-family-mislead-burzynski-4051287","http://stakeholders.ofcom.org.uk/binaries/enforcement/broadcast-bulletins/243/obb243.pdf","http://www.reportingonhealth.org/2014/01/12/qa-liz-szabo-braving-legal-threats-investigate-medical-folk-hero","http://www.houstonpress.com/news/the-10-most-embarrassing-houstonians-7681068","http://www.ministryoftruth.me.uk/wp-content/uploads/2011/11/tmbvsburzynski.pdf","http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM326631.pdf","http://www.sciencebasedmedicine.org/burzynski-cancer-is-a-serious-business-part-2-like-the-first-burzynski-movie-only-more-so/","http://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/burzynski1.html","http://www.burzynskiclinic.com","https://www.sec.gov/Archives/edgar/data/724445/000110465911032257/a11-13213_110k.htm"],"sections":[{"toclevel":1,"level":"2","line":"Stanislaw Burzynski","number":"1","index":"1","fromtitle":"Burzynski_Clinic","byteoffset":817,"anchor":"Stanislaw_Burzynski"},{"toclevel":1,"level":"2","line":"Antineoplaston therapy","number":"2","index":"2","fromtitle":"Burzynski_Clinic","byteoffset":4530,"anchor":"Antineoplaston_therapy"},{"toclevel":2,"level":"3","line":"Clinical trials","number":"2.1","index":"3","fromtitle":"Burzynski_Clinic","byteoffset":9479,"anchor":"Clinical_trials"},{"toclevel":2,"level":"3","line":"Efficacy","number":"2.2","index":"4","fromtitle":"Burzynski_Clinic","byteoffset":13116,"anchor":"Efficacy"},{"toclevel":2,"level":"3","line":"Cost","number":"2.3","index":"5","fromtitle":"Burzynski_Clinic","byteoffset":18382,"anchor":"Cost"},{"toclevel":1,"level":"2","line":"Legal issues","number":"3","index":"6","fromtitle":"Burzynski_Clinic","byteoffset":19167,"anchor":"Legal_issues"},{"toclevel":2,"level":"3","line":"FDA warnings","number":"3.1","index":"7","fromtitle":"Burzynski_Clinic","byteoffset":19187,"anchor":"FDA_warnings"},{"toclevel":2,"level":"3","line":"Texas Medical Board","number":"3.2","index":"8","fromtitle":"Burzynski_Clinic","byteoffset":30108,"anchor":"Texas_Medical_Board"},{"toclevel":2,"level":"3","line":"Lawsuits","number":"3.3","index":"9","fromtitle":"Burzynski_Clinic","byteoffset":36221,"anchor":"Lawsuits"},{"toclevel":2,"level":"3","line":"Legal threats to online critics","number":"3.4","index":"10","fromtitle":"Burzynski_Clinic","byteoffset":38806,"anchor":"Legal_threats_to_online_critics"},{"toclevel":1,"level":"2","line":"Media and commentary","number":"4","index":"11","fromtitle":"Burzynski_Clinic","byteoffset":45678,"anchor":"Media_and_commentary"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"12","fromtitle":"Burzynski_Clinic","byteoffset":51403,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"6","index":"13","fromtitle":"Burzynski_Clinic","byteoffset":51439,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"7","index":"14","fromtitle":"Burzynski_Clinic","byteoffset":52060,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Burzynski Clinic","iwlinks":[],"properties":[{"name":"defaultsort","*":"Burzynski, Stanislaw"},{"name":"wikibase_item","*":"Q15178216"}]}}